JPH0315632B2 - - Google Patents
Info
- Publication number
- JPH0315632B2 JPH0315632B2 JP57098576A JP9857682A JPH0315632B2 JP H0315632 B2 JPH0315632 B2 JP H0315632B2 JP 57098576 A JP57098576 A JP 57098576A JP 9857682 A JP9857682 A JP 9857682A JP H0315632 B2 JPH0315632 B2 JP H0315632B2
- Authority
- JP
- Japan
- Prior art keywords
- acid
- compound
- gluconate
- piperazinyl
- dihydro
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 150000001875 compounds Chemical class 0.000 claims description 84
- RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 claims description 52
- RGHNJXZEOKUKBD-SQOUGZDYSA-M D-gluconate Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O RGHNJXZEOKUKBD-SQOUGZDYSA-M 0.000 claims description 39
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 claims description 27
- 235000012208 gluconic acid Nutrition 0.000 claims description 27
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 claims description 26
- 239000002253 acid Substances 0.000 claims description 25
- 229940050410 gluconate Drugs 0.000 claims description 24
- 239000000174 gluconic acid Substances 0.000 claims description 24
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 claims description 23
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 claims description 20
- IAJILQKETJEXLJ-RSJOWCBRSA-N aldehydo-D-galacturonic acid Chemical compound O=C[C@H](O)[C@@H](O)[C@@H](O)[C@H](O)C(O)=O IAJILQKETJEXLJ-RSJOWCBRSA-N 0.000 claims description 20
- 235000003704 aspartic acid Nutrition 0.000 claims description 19
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 claims description 19
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 claims description 18
- 239000004220 glutamic acid Substances 0.000 claims description 18
- 235000013922 glutamic acid Nutrition 0.000 claims description 18
- 239000008194 pharmaceutical composition Substances 0.000 claims description 15
- 239000003937 drug carrier Substances 0.000 claims description 8
- AEMOLEFTQBMNLQ-BKBMJHBISA-N alpha-D-galacturonic acid Chemical compound O[C@H]1O[C@H](C(O)=O)[C@H](O)[C@H](O)[C@H]1O AEMOLEFTQBMNLQ-BKBMJHBISA-N 0.000 claims description 7
- 230000000844 anti-bacterial effect Effects 0.000 claims description 7
- 229940009098 aspartate Drugs 0.000 claims description 7
- LOAUVZALPPNFOQ-UHFFFAOYSA-N quinaldic acid Chemical compound C1=CC=CC2=NC(C(=O)O)=CC=C21 LOAUVZALPPNFOQ-UHFFFAOYSA-N 0.000 claims description 7
- 229930195712 glutamate Natural products 0.000 claims description 5
- WDBKTCSSCMNXLF-HVDRVSQOSA-N N[C@@H](CCC(=O)O)C(=O)O.N1=C(C=CC2=CC=CC=C12)C(=O)O Chemical compound N[C@@H](CCC(=O)O)C(=O)O.N1=C(C=CC2=CC=CC=C12)C(=O)O WDBKTCSSCMNXLF-HVDRVSQOSA-N 0.000 claims description 2
- CGXLVFZJJOXEDF-UHFFFAOYSA-N 1,8-naphthyridine-3-carboxylic acid Chemical compound N1=CC=CC2=CC(C(=O)O)=CN=C21 CGXLVFZJJOXEDF-UHFFFAOYSA-N 0.000 claims 1
- 150000003839 salts Chemical class 0.000 description 38
- 239000000243 solution Substances 0.000 description 37
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 35
- 239000000203 mixture Substances 0.000 description 21
- 229950006191 gluconic acid Drugs 0.000 description 20
- 238000000034 method Methods 0.000 description 20
- 229940126062 Compound A Drugs 0.000 description 16
- NLDMNSXOCDLTTB-UHFFFAOYSA-N Heterophylliin A Natural products O1C2COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC2C(OC(=O)C=2C=C(O)C(O)=C(O)C=2)C(O)C1OC(=O)C1=CC(O)=C(O)C(O)=C1 NLDMNSXOCDLTTB-UHFFFAOYSA-N 0.000 description 16
- 239000006201 parenteral dosage form Substances 0.000 description 12
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 11
- 238000003756 stirring Methods 0.000 description 10
- 239000002775 capsule Substances 0.000 description 9
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 8
- 241000124008 Mammalia Species 0.000 description 8
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 7
- 239000000843 powder Substances 0.000 description 7
- 239000003153 chemical reaction reagent Substances 0.000 description 6
- 239000007788 liquid Substances 0.000 description 6
- 239000006186 oral dosage form Substances 0.000 description 6
- 239000000725 suspension Substances 0.000 description 6
- 239000003826 tablet Substances 0.000 description 6
- 239000008215 water for injection Substances 0.000 description 6
- 208000035143 Bacterial infection Diseases 0.000 description 5
- 150000007513 acids Chemical class 0.000 description 5
- 239000004480 active ingredient Substances 0.000 description 5
- 208000022362 bacterial infectious disease Diseases 0.000 description 5
- 238000002512 chemotherapy Methods 0.000 description 5
- JNGZXGGOCLZBFB-IVCQMTBJSA-N compound E Chemical compound N([C@@H](C)C(=O)N[C@@H]1C(N(C)C2=CC=CC=C2C(C=2C=CC=CC=2)=N1)=O)C(=O)CC1=CC(F)=CC(F)=C1 JNGZXGGOCLZBFB-IVCQMTBJSA-N 0.000 description 5
- 239000013078 crystal Substances 0.000 description 5
- 238000001990 intravenous administration Methods 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- 239000002904 solvent Substances 0.000 description 5
- 239000000829 suppository Substances 0.000 description 5
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- 125000000422 delta-lactone group Chemical group 0.000 description 4
- 239000002552 dosage form Substances 0.000 description 4
- IDYZIJYBMGIQMJ-UHFFFAOYSA-N enoxacin Chemical compound N1=C2N(CC)C=C(C(O)=O)C(=O)C2=CC(F)=C1N1CCNCC1 IDYZIJYBMGIQMJ-UHFFFAOYSA-N 0.000 description 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 4
- 239000007787 solid Substances 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- QCQCHGYLTSGIGX-GHXANHINSA-N 4-[[(3ar,5ar,5br,7ar,9s,11ar,11br,13as)-5a,5b,8,8,11a-pentamethyl-3a-[(5-methylpyridine-3-carbonyl)amino]-2-oxo-1-propan-2-yl-4,5,6,7,7a,9,10,11,11b,12,13,13a-dodecahydro-3h-cyclopenta[a]chrysen-9-yl]oxy]-2,2-dimethyl-4-oxobutanoic acid Chemical compound N([C@@]12CC[C@@]3(C)[C@]4(C)CC[C@H]5C(C)(C)[C@@H](OC(=O)CC(C)(C)C(O)=O)CC[C@]5(C)[C@H]4CC[C@@H]3C1=C(C(C2)=O)C(C)C)C(=O)C1=CN=CC(C)=C1 QCQCHGYLTSGIGX-GHXANHINSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 241000234427 Asparagus Species 0.000 description 3
- 235000005340 Asparagus officinalis Nutrition 0.000 description 3
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 3
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 3
- 239000004599 antimicrobial Substances 0.000 description 3
- 238000000354 decomposition reaction Methods 0.000 description 3
- 238000010790 dilution Methods 0.000 description 3
- 239000012895 dilution Substances 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 239000008101 lactose Substances 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 150000004682 monohydrates Chemical class 0.000 description 3
- OGJPXUAPXNRGGI-UHFFFAOYSA-N norfloxacin Chemical compound C1=C2N(CC)C=C(C(O)=O)C(=O)C2=CC(F)=C1N1CCNCC1 OGJPXUAPXNRGGI-UHFFFAOYSA-N 0.000 description 3
- 238000012216 screening Methods 0.000 description 3
- DKNNITGJCMPHKE-UHFFFAOYSA-N 1-ethyl-6-fluoro-4-oxo-7-piperazin-1-yl-1,8-naphthyridine-3-carboxylic acid;trihydrate Chemical compound O.O.O.N1=C2N(CC)C=C(C(O)=O)C(=O)C2=CC(F)=C1N1CCNCC1.N1=C2N(CC)C=C(C(O)=O)C(=O)C2=CC(F)=C1N1CCNCC1 DKNNITGJCMPHKE-UHFFFAOYSA-N 0.000 description 2
- ITBINNOMHXTMLQ-UHFFFAOYSA-N 1-ethyl-6-fluoro-4-oxo-7-piperazin-1-ylquinoline-3-carboxylic acid;hydrate Chemical compound O.C1=C2N(CC)C=C(C(O)=O)C(=O)C2=CC(F)=C1N1CCNCC1 ITBINNOMHXTMLQ-UHFFFAOYSA-N 0.000 description 2
- 229920002261 Corn starch Polymers 0.000 description 2
- SKCKOFZKJLZSFA-UHFFFAOYSA-N L-Gulomethylit Natural products CC(O)C(O)C(O)C(O)CO SKCKOFZKJLZSFA-UHFFFAOYSA-N 0.000 description 2
- 229910019142 PO4 Inorganic materials 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- 239000004353 Polyethylene glycol 8000 Substances 0.000 description 2
- 235000001014 amino acid Nutrition 0.000 description 2
- 229940024606 amino acid Drugs 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 239000008120 corn starch Substances 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 238000004108 freeze drying Methods 0.000 description 2
- 229940049906 glutamate Drugs 0.000 description 2
- 229960000443 hydrochloric acid Drugs 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 238000011065 in-situ storage Methods 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 239000004310 lactic acid Substances 0.000 description 2
- 229960000448 lactic acid Drugs 0.000 description 2
- 235000014655 lactic acid Nutrition 0.000 description 2
- 150000007522 mineralic acids Chemical class 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 2
- 239000010452 phosphate Substances 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 229940085678 polyethylene glycol 8000 Drugs 0.000 description 2
- 235000019446 polyethylene glycol 8000 Nutrition 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 238000010561 standard procedure Methods 0.000 description 2
- 238000010998 test method Methods 0.000 description 2
- RQCGHKGWKBQYJQ-HVDRVSQOSA-N (2s)-2-aminopentanedioic acid;1-ethyl-6-fluoro-4-oxo-7-piperazin-1-yl-1,8-naphthyridine-3-carboxylic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O.N1=C2N(CC)C=C(C(O)=O)C(=O)C2=CC(F)=C1N1CCNCC1 RQCGHKGWKBQYJQ-HVDRVSQOSA-N 0.000 description 1
- UOQHWNPVNXSDDO-UHFFFAOYSA-N 3-bromoimidazo[1,2-a]pyridine-6-carbonitrile Chemical compound C1=CC(C#N)=CN2C(Br)=CN=C21 UOQHWNPVNXSDDO-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 241000193403 Clostridium Species 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- PHOQVHQSTUBQQK-SQOUGZDYSA-N D-glucono-1,5-lactone Chemical compound OC[C@H]1OC(=O)[C@H](O)[C@@H](O)[C@@H]1O PHOQVHQSTUBQQK-SQOUGZDYSA-N 0.000 description 1
- 241000588914 Enterobacter Species 0.000 description 1
- 241000588722 Escherichia Species 0.000 description 1
- 241000606790 Haemophilus Species 0.000 description 1
- 241000588748 Klebsiella Species 0.000 description 1
- XVOYSCVBGLVSOL-UHFFFAOYSA-N L-cysteine sulfonic acid Natural products OC(=O)C(N)CS(O)(=O)=O XVOYSCVBGLVSOL-UHFFFAOYSA-N 0.000 description 1
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 1
- 241000588653 Neisseria Species 0.000 description 1
- 241000588769 Proteus <enterobacteria> Species 0.000 description 1
- 241000588768 Providencia Species 0.000 description 1
- 241000589516 Pseudomonas Species 0.000 description 1
- 241000607720 Serratia Species 0.000 description 1
- 241000191940 Staphylococcus Species 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- 208000003443 Unconsciousness Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 238000000862 absorption spectrum Methods 0.000 description 1
- 159000000021 acetate salts Chemical class 0.000 description 1
- 229960000583 acetic acid Drugs 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 239000007900 aqueous suspension Substances 0.000 description 1
- 230000036765 blood level Effects 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 235000010980 cellulose Nutrition 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 239000007891 compressed tablet Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 238000001212 derivatisation Methods 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 229940093915 gynecological organic acid Drugs 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000013383 initial experiment Methods 0.000 description 1
- 239000007972 injectable composition Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 239000002198 insoluble material Substances 0.000 description 1
- 238000010255 intramuscular injection Methods 0.000 description 1
- 238000010253 intravenous injection Methods 0.000 description 1
- SUMDYPCJJOFFON-UHFFFAOYSA-N isethionic acid Chemical class OCCS(O)(=O)=O SUMDYPCJJOFFON-UHFFFAOYSA-N 0.000 description 1
- 150000003893 lactate salts Chemical class 0.000 description 1
- 229940099563 lactobionic acid Drugs 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000000155 melt Substances 0.000 description 1
- 229940098779 methanesulfonic acid Drugs 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 1
- 239000008108 microcrystalline cellulose Substances 0.000 description 1
- 229940016286 microcrystalline cellulose Drugs 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 235000006408 oxalic acid Nutrition 0.000 description 1
- 239000003182 parenteral nutrition solution Substances 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000005096 rolling process Methods 0.000 description 1
- GJPYYNMJTJNYTO-UHFFFAOYSA-J sodium aluminium sulfate Chemical compound [Na+].[Al+3].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O GJPYYNMJTJNYTO-UHFFFAOYSA-J 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 239000011877 solvent mixture Substances 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
Landscapes
- Quinoline Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Description
äžè¬çã«å»è¬åã¯çµå£çµè·¯ã«ããæã䟿å©ã«äºº
ã«æäžããããåŸã€ãŠå®å®ãªçµå£çæäžè¬åœ¢æ ã
ãšãã°é å€ãã«ãã»ã«å€ããã³çµå£ç液äœã¯æã
äžè¬çã«è£œé ãããããããã®åã®çµå£çæè¬åœ¢
æ ã«ãããŠã¯å«æããã掻æ§æåã®æº¶è§£åºŠã¯äžè¬
çã«åé¡ã§ã¯ãªãããªããªãã°ç©è³ªãæ¶å管å ã«
ååšããæéãé·ãããšã«ããããããŠäžè¬çãª
æ¶åéçšã«ããåžåãä¿é²ãããããã§ãããã
ã¡ãã極ããŠé£æº¶æ§ã®ç©è³ªã¯çµå£æäžããå Žåã«
ãã€ãããšåžåãããã ãã§ãããæäžãããè¬
ç©ã®äžéšã¯ææ³ãããå¯èœæ§ããããåŸã€ãŠå å
ã«æãŸããè¬ç©ã®å¹æãçºæ®ã§ããªããåŸã€ãŠã
ã®ãããªç©è³ªã®æº¶è§£åºŠãæ¹åããããã®æ¹æ³ã¯æ
å¹ãªçµå£çæè¬åœ¢æ ã補é ããããã«é©çšããã
ã°ãªããªããåœæ¥è ã«ãããŠç¥ãããŠãããã®ã
ããªæ¹æ³ã®äžã€ã¯è¬ç©ã®æº¶è§£æ§ã®å¡©ã補é ããã
ãšã§ããã å€ãã®å Žåã«çµå£çãªæäžçµè·¯ã¯äœ¿çšããããš
ãã§ããªãããŸãã¯å¥œãŸãããªããããšãã°äººã«
ããã埮çç©ææãæ²»çããå Žåã«ã¯ãéçµå£ç
ãªæäžçµè·¯ããã°ãã°å¥œãŸããããŸãå®éã«å¿ èŠ
ã§ããã ããšãã°ç¹å®æèå€ã®é«ãè¡äžæ¿åºŠãè¿ éã«åŸ
ãããã«ã¯éèå æäžããã°ãã°äœ¿çšããããé·
æéã«ããã€ãŠç¹å®ãšè¡äžã¬ãã«ãä¿æãããã
ã«ãã€ããããéèå æ³šå ¥ã䜿çšããããšãã§ã
ããå°å ç§ã®è匱ãªãŸãã¯ç¡æèã®æ£è ãæ²»çã
ãããã«ã¯çèå ããã³éèå 泚å°ã䜿çšããã
ãšãã§ããã å®å®ãªéçµå£çæè¬åœ¢æ ã補é ãããããããŸ
ãã¯äœ¿çšçŽåã«éçµå£çãªæè¬åœ¢æ ã«ããããšã
ã§ããå®å®ãªæè¬åœ¢æ ã補é ããããã«å¿ èŠãªæŽ»
æ§æåã®ç¹åŸŽã¯ãåäžã®æŽ»æ§æåãå«æããçµå£
çæè¬åœ¢æ ã«å¯ŸããŠèŠæ±ããããã®ãšã¯ç°ãªã€ãŠ
ããããã®ããã«éçµå£çåŠæ¹ç©ã«å¯ŸããŠã¯æŽ»æ§
æåã¯ããèªäœå°ãªããšã以äžã®ç¹åŸŽãæããŠã
ãªããã°ãªããªããããŸãã¯ãã®ãããªç¹åŸŽãæ
ããèªå°äœïŒããšãã°å¡©ïŒã«å€æããªããã°ãªã
ãªãã (a) è¡æ¶²ããã³çèçµç¹ãšé©åãããããŠçŽ°èæ§
é ãå·ã€ããªããããªPH奜ãŸããã¯çŽPHïŒãïŒ
ã«ãããæ°Žäžã§ã®é«ã溶解床ã (b) 奜ãŸããã¯å®€æž©ã§äžã€ç©ºæ°ã®ååšäžã«ããã
溶液äžã§ã®å®å®æ§ã (c) æ¯èŒçç¡æ¯æ§ã§äžã€è¬å€èª¿ç¯äœçšã«é¢ããŠèš±
容ãããè©Šè¬ïŒããªãã¡é žãŸãã¯å¡©åºïŒãçšã
ãŠèªå°äœåãããã (d) èªå°äœåè©Šè¬ã¯æ¯èŒçå®äŸ¡ã§ããã¹ãã§ã
ãã (e) èªå°äœã¯å®¹æã«çæããããããŠåçµä¹Ÿç¥ã«
ããå®å®ãªåœ¢æ ãçæãã¹ãã§ããã (f) èªå°äœã¯äŸ¿å©ã«æäžããããã®æšæºçãªéçµ
å£ç溶液ãšé©åãããããŠããã«å åã«æº¶è§£ã
ã¹ãã§ããã æè¿ïŒçš®ã®æ°èŠãªæèå€ãå ±åããããããšã
ã°ïŒâãšãã«âïŒâãã«ãªãâïŒïŒïŒâãžããã
âïŒâãªããœâïŒâïŒïŒâããã©ãžãã«ïŒâïŒâã
ããªã³ã«ã«ãã³é žïŒä»¥äžå Žåã«ãããååç©ïŒ¡ã
ãšç§°ããïŒã®æèäœçšã¯ãAntimicrobial Agent
and Chemotherapyã第17巻第103ã108é ïŒ1980
幎ïŒããã³ãAntimicrobial Agents and
Chemotherapyã第19巻第188ã189é ïŒ1981幎ïŒ
ã«å ±åãããŠããããããã¯åç §ãšããŠæ¬æ现æž
äžã«å«ãŸãããïŒâãšãã«âïŒâãã«ãªãâïŒïŒ
ïŒâãžãããâïŒâãªããœâïŒâïŒïŒâããã©ãž
ãã«ïŒâïŒïŒïŒâããããªãžã³âïŒâã«ã«ãã³é ž
ïŒä»¥äžå Žåã«ãããååç©ïŒ¢ããšç§°ããïŒã®æè
äœçšã¯ãCurrent Chemotherapy and
Infectious Diseaseã Proceedings of the
11th International Congress of Chemotherapy
and the 19th Interscience Conference on
Antimicrobial Agents and Chemotherapyã第
ïŒå·»ç¬¬451é ïŒã¢ã¡ãªã«åŸ®çç©åŠäŒ1980幎çºè¡ïŒ
ã«å ±åãããŠããããã®æç®ã¯åç §ãšããŠæ¬æ现
æžäžã«å«ãŸããã ååç©ïŒ¡ã¯ãŸãç±³åœç¹èš±ç¬¬4146719å·æ现æžã«
ãèšèŒãããŠãããããã¯åç §ãšããŠæ¬æ现æžäž
ã«å«ãŸããããã®ååç©ã¯äž¡æ§ã§ããããããŠé«
床ã®æ°Žæº¶æ§ãæããªãããã®ç¹èš±ã«ã¯å¡©é žå¡©ã®è£œ
é ã ããé瀺ãããŠããã以äžã«è«è°ãããçç±
ã§ãã®å¡©ã¯çš®ã ã®é žããã³å¡©åºãã補é ãããä»
ã®å€ãã®ååç©ïŒ¡ã®å¡©ãšåæ§ã«ãååç©ïŒ¡ãå«æ
ããéçµå£çæè¬åœ¢æ ã補é ããã®ã«ã¯äžé©åœã§
ãããåŸã€ãŠæçšãªéçµå£çæè¬åœ¢æ ã補é ã§ã
ãããã«äžèšã®ç¹åŸŽãæããååç©ïŒ¡ã®èªå°äœã
æäŸããããšã¯æçã§ããäžã€æå©ã§ãããã å¡©é žå¡©ãšããŠã®ååç©ïŒ¢ã¯è±åœç¹èš±åºé¡ç¬¬
2034698å·æ现æžã®å®æœäŸïŒã«ãããŠè£œé ãããŠ
ãããæè¬åœ¢æ ã¯èšèŒãããŠããªãã ååç©ïŒ¢ã¯ãŸããšãŒãããç¹èš±åºé¡ç¬¬9425å·æ
现æžã«ãèšèŒãããŠãããããã¯åç §ãšããŠæ¬æ
现æžäžã«å«ãŸãããååç©ïŒ¢ã¯äž¡æ§ã§ãããé«åºŠ
ã®æ°Žæº¶æ§ãæããªãããã®ç¹èš±ã«ã¯ç¹ã«ååç©ïŒ¢
ã®å¡©ã¯ãçš®ã ã®ç¡æ©é žããã³ææ©é žããçæãã
ããšãã§ãããããŠé©åœãªé žã®äŸã¯å¡©é žãé ¢é žã
ä¹³é žããã¯ãé žãã©ã¯ãããªã³é žããã³ã¡ã¿ã³ã¹
ã«ãã³é žã§ãããç¹ã«å¥œãŸããå¡©ã¯å¡©é žå¡©ãŸãã¯
ã¡ã¿ã³ã¹ã«ãã³é žå¡©ã§ããããšããããšãé瀺ã
ããŠããããã®ç¹èš±ã«ã¯ãŸãå¡©ã補é ããããã«
èé žã䜿çšããããšãã§ãããšèšèŒãããŠããã
以äžã«è«è°ãããçç±ãããããã®å¡©ãªãã³ã«
çš®ã ã®é žããã³å¡©åºãã補é ãããä»ã®å€ãã®å¡©
ã¯ãååç©ïŒ¢ãå«æããæçšãªéçµå£çæè¬åœ¢æ
ã補é ããã®ã«äžé©åœã§ããã ååç©ïŒ¢ã®äœ¿çšã«é¢ããŠã¯ãšãŒãããç¹èš±åºé¡
第9425å·æ现æžã«ã¯ãã®çºæã®ååç©ã¯å»è¬åãš
ããŠããšãã°çµå£çãŸãã¯å±æçé©çšã«é©åœãªæ
æ©ãŸãã¯ç¡æ©ã®è¬åŠçã«èš±å®¹ãããåºäœç¶ãŸãã¯
液äœç¶ã®è£å©å€ãšæ··åããŠããããå«æããè¬åŠ
ç補å€ã®åœ¢æ ã§äœ¿çšã§ããæšèšèŒãããŠãããã
ã®ç¹èš±ã«ã¯ç¶ããŠè¬åŠç補å€ã¯ç²æ«ãé¡ç²å€ãé
å€ãè»èãåå€ãã¯ãªãŒã ãã«ãã»ã«å€ãªã©ã§ã
ã€ãŠãããæšãèšèŒãããŠããã ããã«ãã®ç¹èš±ã«å ±åãããŠãããã¹ãŠã®çäœ
å è©Šéšæ¹æ³ããªãã¡å®æœäŸïŒ¢ãã§ã¯çµå£çãæ
äžçµè·¯ã䜿çšãããŠããããããã«æè¬åœ¢æ ã®è£œ
é äŸããªãã¡å®æœäŸïŒšããã³ïŒªãçµå£çæè¬åœ¢æ
ïŒããããã«ãã»ã«å€ããã³é å€ïŒã«å¯ŸããäŸã§
ããã ãããã®çºæè ã¯æçšãªéçµå£çæè¬åœ¢æ ãå
åç©ïŒ¢ãã容æã«è£œé ã§ããªãããšãèªããŠãã
ãšæšæž¬ããããšãã§ããããªããªãã°ãããã®é
èŠãªæè¬åœ¢æ ã®è£œé ããã³äœ¿çšã«é¢ããŠã¯ããã«
æ瀺ãããŠããªããããŸãèæ ®ãããŠãããªãã
ãã§ããã åŸã€ãŠæçšãªéçµå£çæè¬åœ¢æ ã補é ã§ããã
ãã®äžèšã®ç¹åŸŽãæããååç©ïŒ¢ã®èªå°äœãæäŸ
ããããšã¯æçã§äžã€æå©ã§ãããã ååç©ã«é¢ããç·æ¬ç芳ç¹ã«ãããŠæ¬çºæã¯æ§
é åŒïŒ£ ïŒãã ãåŒäžãã¯ïŒ®ãŸãã¯CHã§ããããããŠ
ã¯ã¬ã©ã¯ããŠãã³é žãã¢ã¹ãã©ã®ã³é žãã°ã«ã³
ã³é žãŸãã¯ã°ã«ã¿ãã³é žã§ããïŒãæããååç©
ã«ããã ååç©ã«é¢ãã第ïŒã®äžäœæŠå¿µã«ãããŠæ¬çºæ
ã¯æ§é åŒïŒ€ ïŒãã ãåŒäžãã¯ã¬ã©ã¯ããŠãã³é žãã¢ã¹ãã©
ã®ã³é žãã°ã«ã³ã³é žãŸãã¯ã°ã«ã¿ãã³é žã§ããïŒ
ãæããååç©ã«ãã ååç©ã«é¢ãã第ïŒã®äžäœæŠå¿µã«ãããŠæ¬çºæ
ã¯æ§é åŒïŒ¥ ïŒãã ãã¯ã¬ã©ã¯ããŠãã³é žãã¢ã¹ãã©ã®ã³
é žãã°ã«ã³ã³é žãŸãã¯ã°ã«ã¿ãã³é žã§ããïŒãæ
ããååç©ã«ããã ååç©ã«é¢ãã第ïŒã®å ·äœç芳ç¹ã«ãããŠæ¬çº
æã¯ïŒâãšãã«âïŒâãã«ãªãâïŒïŒïŒâãžãã
ãâïŒâãªããœâïŒâïŒïŒâããã©ãžãã«ïŒâïŒïŒ
ïŒâããããªãžã³âïŒâã«ã«ãã³é žã¬ã©ã¯ããŠã
ã³é žå¡©ã«ããã ååç©ã«é¢ãã第ïŒã®å ·äœç芳ç¹ã«ãããŠæ¬çº
æã¯ïŒâãšãã«âïŒâãã«ãªãâïŒïŒïŒâãžãã
ãâïŒâãªããœâïŒâïŒïŒâããã©ãžãã«ïŒâïŒïŒ
ïŒâããããªãžã³âïŒâã«ã«ãã³é žã¢ã¹ãã©ã®ã³
é žå¡©ã«ããã ååç©ã«é¢ãã第ïŒã®å ·äœç芳ç¹ã«ãããŠæ¬çº
æã¯ïŒâãšãã«âïŒâãã«ãªãâïŒïŒïŒâãžãã
ãâïŒâãªããœâïŒâïŒïŒâããã©ãžãã«ïŒâïŒïŒ
ïŒâããããªãžã³âïŒâã«ã«ãã³é žã°ã«ã³ã³é žå¡©
ã«ããã ååç©ã«é¢ãã第ïŒã®å ·äœç芳ç¹ã«ãããŠæ¬çº
æã¯ïŒâãšãã«âïŒâãã«ãªãâïŒïŒïŒâãžãã
ãâïŒâãªããœâïŒâïŒïŒâããã©ãžãã«ïŒâïŒïŒ
ïŒâããããªãžã³âïŒâã«ã«ãã³é žã°ã«ã¿ãã³é ž
å¡©ã«ããã ååç©ã«é¢ãã第ïŒã®å ·äœç芳ç¹ã«ãããŠæ¬çº
æã¯ïŒâãšãã«âïŒâãã«ãªãâïŒïŒïŒâãžãã
ãâïŒâãªããœâïŒâïŒïŒâããã©ãžãã«ïŒâïŒâ
ãããªã³ã«ã«ãã³é žã¬ã©ã¯ããŠãã³é žå¡©ã«ããã ååç©ã«é¢ãã第ïŒã®å ·äœç芳ç¹ã«ãããŠæ¬çº
æã¯ïŒâãšãã«âïŒâãã«ãªãâïŒïŒïŒâãžãã
ãâïŒâãªããœâïŒâïŒïŒâããã©ãžãã«ïŒâïŒâ
ãããªã³ã«ã«ãã³é žã¢ã¹ãã©ã®ã³é žå¡©ã«ããã ååç©ã«é¢ãã第ïŒã®å ·äœç芳ç¹ã«ãããŠæ¬çº
æã¯ïŒâãšãã«âïŒâãã«ãªãâïŒïŒïŒâãžãã
ãâïŒâãªããœâïŒâïŒïŒâããã©ãžãã«ïŒâïŒâ
ãããªã³ã«ã«ãã³é žã°ã«ã³ã³é žå¡©ã«ããã ååç©ã«é¢ãã第ïŒã®å ·äœç芳ç¹ã«ãããŠæ¬çº
æã¯ïŒâãšãã«âïŒâãã«ãªãâïŒïŒïŒâãžãã
ãâïŒâãªããœâïŒâïŒïŒâããã©ãžãã«ïŒâïŒâ
ãããªã³ã«ã«ãã³é žã°ã«ã¿ãã³é žå¡©ã«ããã è¬åŠççµæç©ã«é¢ããç·æ¬ç芳ç¹ã«ãããŠæ¬çº
æã¯è¬åŠçã«èš±å®¹ãããæ äœãšçµåãããŠæ§é åŒ
 ïŒãã ãåŒäžãã¯ïŒ®ãŸãã¯CHã§ããããããŠ
ã¯ã¬ã©ã¯ããŠãã³é žãã¢ã¹ãã©ã®ã³é žãã°ã«ã³
ã³é žããŸãã¯ã°ã«ã¿ãã³é žã§ããïŒãæããåå
ç©ãå«ãæèæ§ã®è¬åŠççµæç©ã«ããã è¬åŠççµæç©ã«é¢ãã第ïŒã®äžäœæŠå¿µã«ãããŠ
æ¬çºæã¯è¬åŠçã«èš±å®¹ãããæ äœãšçµåãããŠæ§
é åŒïŒ€ ïŒãã ãåŒäžãã¯ã¬ã©ã¯ããŠãã³é žãã¢ã¹ãã©
ã®ã³é žãã°ã«ã³ã³é žãŸãã¯ã°ã«ã¿ãã³é žã§ããïŒ
ãæããååç©ãå«ãæèæ§ã®è¬åŠççµæç©ã«ã
ãã è¬åŠççµæç©ã«é¢ãã第ïŒã®äžäœæŠå¿µã«ãããŠ
æ¬çºæã¯è¬åŠçã«èš±å®¹ãããæ äœãšçµåãããŠæ§
é åŒïŒ¥ ïŒãã ãåŒäžãã¯ã¬ã©ã¯ããŠãã³é žãã¢ã¹ãã©
ã®ã³é žãã°ã«ã³ã³é žãŸãã¯ã°ã«ã¿ãã³é žã§ããïŒ
ãæããååç©ãå«ãæèæ§ã®è¬åŠççµæç©ã«ã
ãã è¬åŠççµæç©ã«é¢ãã第ïŒã®äžäœæŠå¿µã«ãããŠ
æ¬çºæã¯è¬åŠçã«èš±å®¹ãããæ äœãšçµåããã§æ§
é åŒïŒ£ ïŒãã ãåŒäžãã¯ïŒ®ãŸãã¯CHã§ããããããŠ
ã¯ã¬ã©ã¯ããŠãã³é žãã¢ã¹ãã©ã®ã³é žãã°ã«ã³
ã³é žãŸãã¯ã°ã«ã¿ãã³é žã§ããïŒã®ååç©ãå«ã
æèæ§ã®éçµå£çãªè¬åŠççµæç©ã«ããã è¬åŠçæ¹æ³ã«é¢ããç·æ¬ç芳ç¹ã«ãããŠæ¬çºæ
ã¯æ§é åŒïŒ£ ïŒãã ãåŒäžãã¯ïŒ®ãŸãã¯CHã§ããããããŠ
ã¯ã¬ã©ã¯ããŠãã³é žãã¢ã¹ãã©ã®ã³é žãã°ã«ã³
ã³é žãŸãã¯ã°ã«ã¿ãã³é žã§ããïŒãæããååç©
ã®æå¹äœçšéãäžèšã®ãããªåºä¹³åç©ã«æäžãã
ããšãããªãã现èææçã«ããã€ãŠããåºä¹³å
ç©ã®æ²»çæ¹æ³ã«ããã è¬åŠçæ¹æ³ã«é¢ãã第ïŒã®äžäœæŠå¿µã«ãããŠæ¬
çºæã¯è¬åŠçã«èš±å®¹ãããæ äœãšçµã¿åããã§æ§
é åŒïŒ£ ïŒãã ãåŒäžãã¯ïŒ®ãŸãã¯CHã§ããããããŠ
ã¯ã¬ã©ã¯ããŠãã³é žãã¢ã¹ãã©ã®ã³é žãã°ã«ã³
ã³é žãŸãã¯ã°ã«ã¿ãã³é žã§ããïŒãæããååç©
ãå«ãè¬åŠççµæç©ã®æå¹äœçšéãäžèšã®ãããª
åºä¹³åç©ã«æäžããããšãããªãã现èææçã«
ããã€ãŠããåºä¹³åç©ã®æ²»çæ¹æ³ã«ããã è¬åŠçæ¹æ³ã«é¢ãã第ïŒã®äžäœæŠå¿µã«ãããŠæ¬
çºæã¯ãè¬åŠçã«èš±å®¹ãããéçµå£çæ äœãšçµå
ãããŠæ§é åŒïŒ£ ïŒãã ãåŒäžãã¯ïŒ®ãŸãã¯CHã§ããããããŠ
ã¯ã¬ã©ã¯ããŠãã³é žãã¢ã¹ãã©ã®ã³é žãã°ã«ã³
ã³é žãŸãã¯ã°ã«ã¿ãã³é žã§ããïŒãæããååç©
ãå«ãè¬åŠççµæç©ã®æå¹äœçšéãäžèšã®ãããª
åºä¹³åç©ã«éçµå£çã«æäžããããšãããªãã现
èææçã«ããã€ãŠããåºä¹³åç©ãéçµå£çã«æ²»
çããããã®æ¹æ³ã«ããã ååŠçæ¹æ³ã«é¢ãã芳ç¹ã«ãããŠæ¬çºæã¯æ§é
åŒ ïŒãã ãåŒäžãã¯ä»¥äžã«å®çŸ©ãããïŒãæãã
ååç©ã以äžã«å®çŸ©ããããããªåŒïŒºã®é žãšåå¿
ãããããšãããªãæ§é åŒïŒ£ ïŒãã ãåŒäžãã¯ïŒ®ãŸãã¯CHã§ããããããŠ
ã¯ã¬ã©ã¯ããŠãã³é žãã¢ã¹ãã©ã®ã³é žãã°ã«ã³
ã³é žãŸãã¯ã°ã«ã¿ãã³é žã§ããïŒãæããååç©
ã®è£œé æ³ã«ããã ååç©ïŒ¡ããªãã¡ïŒâãšãã«âïŒâãã«ãªãâ
ïŒïŒïŒâãžãããâïŒâãªããœâïŒâïŒïŒâãã
ã©ãžãã«ïŒâïŒâãããªã³ã«ã«ãã³é žã¯ç±³åœç¹èš±
第4146719å·æ现æžã«èšèŒãããããã«ããŠãã
ãŸãã¯ããã«èšèŒãããæ¹æ³ã®æãããªå€æ³ã«ã
ã補é ããããšãã§ããã ååç©ïŒ¢ããªãã¡ïŒâãšãã«âïŒâãã«ãªãâ
ïŒïŒïŒâãžãããâïŒâãªããœâïŒâïŒïŒâãã
ã©ãžãã«ïŒâïŒïŒïŒâããããªãžã³âïŒâã«ã«ã
ã³é žã¯ãšãŒãããç¹èš±åºé¡ç¬¬9425å·æ现æžã«èšèŒ
ãããããã«ããŠããŸãã¯ããã«èšèŒãããæ¹æ³
ã®æãããªå€æ³ã«ãã補é ããããšãã§ããã ååç©ïŒ¡ããã³ïŒ¢ã¯æ¢ç¥ã®æ¹æ³ã§ææ©ããã³ç¡
æ©ã®é žãçšããŠåŠçããããšã«ãããããã®å¯Ÿå¿
ããé žä»å å¡©ã«å€æããããããšãã°ååç©ïŒ¡ã
ãã³ïŒ¢ã¯æº¶æ¶²ãŸãã¯æžæ¿ç©äžã§åäžã®ããŸãã¯ç°
ãªã€ã溶åªäžã«ææã®é žãå«ã溶液ãŸãã¯æžæ¿ç©
ã§åŠçããããšãã§ãããé©åœãªæº¶åªãŸãã¯æº¶åª
æ··åç©ã¯åœæ¥è ãªãã°å®¹æã«éžæã§ããæ¬çºæã®
奜ãŸãã溶åªã¯æ°Žã§ãããæ°Žäžã§å¡©ã補é ããå Ž
åãæ°Žäžã®ååç©ïŒ¡ãŸãã¯ïŒ¢ã®æžæ¿ç©ãæ°Žã«æº¶è§£
ããŠããããŸãã¯æžæ¿ããŠããéžã°ããé žãšãšã
ã«æ¹æããã溶åªåºŠãé«ãããããŠå¡©åœ¢æãå©ã
ãããã«ãã®æ··åç©ãçæéå æž©ããããšãã§ã
ããããšãã°ãã®æžæ¿ç©ãçŽ60âã«å ç±ãããã
ãŠã€ãã«æ¹æããªãã宀枩ã«æ»ãããšãã§ããã
ã°ã«ã³ã³é žå¡©ã補é ããå Žåãã°ã«ã³ã³é žãã«ã¿
ã©ã¯ãã³ããåå¿ã®å Žã§ã°ã«ã³ã³é žã補é ããã®
ãç¹ã«äŸ¿å©ã§ããããšãèŠãåºãããã ããšãã°ã°ã«ã³ã³é žãã«ã¿ã©ã¯ãã³ãååç©ïŒ¡
ãŸãã¯ïŒ¢ã®æ°Žæžæ¿ç©ã«å ãããããŠå®€æž©ã§çŽ20æ
éæ¹æããããã®æ··åç©ãçŽ60âã«çæéå ç±ã
ããšå®å šãªå¡©åœ¢æã«å¿ èŠãªæéãçŽïŒæéã«ççž®
ããã§ãããã塩圢æãæé©åããããã®ãã®æ¹
æ³ã®å€æŽã¯åœæ¥è ã«ã¯å®¹æã«ã§ããã ååç©ïŒ¡ããã³ïŒ¢ãã»ãŒåœã¢ã«éã®å¡©åœ¢æè©Šè¬
ãšæ··åããããšãã§ãããããŸãã¯ææã«ããé
å°ã®å¡©åœ¢æè©Šè¬ã䜿çšããããšãã§ãããå¡©ã¯æš
æºçãªæ¹æ³ããšãã°åçµä¹Ÿç¥ã«ããååããããš
ãã§ãããã€ãã«ææã«ããå¡©ãåçµæ¶ã«ãã粟
補ããããšãã§ããã æ¬æ现æžäžã§äœ¿çšããå Žåãã¬ã©ã¯ããŠãã³
é žãããã¬ã©ã¯ããŠãã³é žå¡©ãããã¢ã¹ãã©ã®ã³é žãã
ãã¢ã¹ãã©ã®ã³é žå¡©ãããã°ã«ã¿ãã³é žãããã°ã«ã¿
ãã³é žå¡©ãããã°ã¯ã³ã³é žãããã°ã«ã³ã³é žå¡©ããã
ã³ãã°ã«ã³ã³é žãã«ã¿ã©ã¯ãã³ããšããçšèªã«ã¯
ãããã®è©Šè¬ã®ããããã®ç°æ§äœãªãã³ã«ããã
ã®ããããã®ç°æ§äœã®æ··åç©ãå«ãŸãããã®ãšã
ããåŸã€ãŠæ¬çºæã«ãããŠã¯ããšãã°äžèšã®å¡©åœ¢
æè©Šè¬ã®ïŒ€ãããã³DLæ··åç©ã®äœ¿çšãèæ ®ã
ããã奜ãŸãã圢æ ã¯å€©ç¶ã«ååšãã圢ïŒã¢ãã
é žã®å Žåã¯ïŒ¬åœ¢ããããŠã°ã«ã³ã³é žãã°ã«ã³ã³é ž
ãã«ã¿ã©ã¯ãã³ããã³ã¬ã©ã¯ããŠãã³é žã®å Žåã¯
圢ïŒã§ããã æ¬çºæã®ååç©ã¯æº¶åªåãããŠããªã圢ãªãã³
ã«æ°Žåããã圢ãå«ããŠæº¶åªåããã圢ãšããŠå
åšããããšãã§ãããäžè¬çã«è¬åŠçã«èš±å®¹ãã
ã溶åªããšãã°æ°Žããšã¿ããŒã«ãªã©ã§æº¶åªåãã
ã圢ã¯ãæ¬çºæã®ç®çã«å¯ŸããŠæº¶åªåãããŠããª
ã圢ãšåçã§ãããæ¬çºæã®ç®çã«å¯ŸããŠã¯åå
ç©ïŒ¡ããã³ïŒ¢ã®å¥œãŸããå¡©ã¯è¬åŠçã«èš±å®¹ããã
å¡©ã§ããããããŠã¬ã©ã¯ããŠãã³é žå¡©ãã¢ã¹ãã©
ã®ã³é žå¡©ãã°ã«ã¿ãã³é žå¡©ããã³ã°ã«ã³ã³é žå¡©ã§
ãããã°ã«ã³ã³é žå¡©ã¯æã奜ãŸããå¡©ã§ãããã
ããŠïŒ€âã°ã«ã³ã³é žãã«ã¿ã©ã¯ãã³ããåå¿ã®å Ž
ã§çæããâã°ã«ã³ã³é žãã補é ãããå Žåã«
ç¹ã«å¥œãŸããã ååç©ïŒ¡ããã³ïŒ¢ãã補é ãããå€æ°ã®è¬åŠç
ã«èš±å®¹ãããé žä»å å¡©ããã³å¡©åºä»å å¡©ã«é¢ãã
ç 究ã«ãããŠãäžèšã®å¥œãŸããå¡©ç¹ã«ã°ã«ã³ã³é ž
å¡©ã¯ååç©ïŒ¡ããã³ïŒ¢ãå«æããæçšãªéçµå£ç
æè¬åœ¢æ ã補é ããã®ã«å¿ èŠãªç¹åŸŽãæããããš
ãèªãããããååç©ïŒ¡ããã³ïŒ¢ããéçµå£çæ
è¬åœ¢æ ã補é ããããã®ãããã®ç¹æ®ãªå¡©ã®æçš
æ§ã¯é©ãã¹ãããšã§ããããããŠå è¡æè¡ããäº
æ³ããããšã¯ã§ããªãã€ããããšãã°åœæ¥è ã¯å
åç©ïŒ¡ããã³ïŒ¢ãå«æããæçšãªéçµå£çæè¬åœ¢
æ ã¯ãå è¡æè¡ã®æç®ã«é瀺ãããŠããé žä»å å¡©
ãã補é ããããšãã§ãããšèããã§ããããé©
ãã¹ãããšã«ã¯äºå®ã¯ããã§ã¯ãªãããããŠç¹ã«
é©ãã¹ãããšã«ã¯æ¬çºæã®å Žåã«ãååç©ïŒ¡ãã
ã³ïŒ¢ã®äž¡æ¹ããéçµå£çæè¬åœ¢æ ã補é ãããã
ã«ã¯äžè¬çãªå¡©é žå¡©ã®äœ¿çšã¯é€å€ãããã 以äžã®è¡šã«ã¯æº¶è§£åºŠããã³PHã®ããŒã¿ãéã
ããã®ã瀺ãããŠãããããã«ããååç©ïŒ¡ãã
ã³ïŒ¢ãã補é ãããè¬åŠçã«èš±å®¹ãããå¡©ã®å€§éš
åã«ãããã®ååç©ãå«æããæçšãªéçµå£çæ
è¬åœ¢æ ã補é ããããã«å©çšã§ããªãããšã瀺ã
ãŠããã
ã«æäžããããåŸã€ãŠå®å®ãªçµå£çæäžè¬åœ¢æ ã
ãšãã°é å€ãã«ãã»ã«å€ããã³çµå£ç液äœã¯æã
äžè¬çã«è£œé ãããããããã®åã®çµå£çæè¬åœ¢
æ ã«ãããŠã¯å«æããã掻æ§æåã®æº¶è§£åºŠã¯äžè¬
çã«åé¡ã§ã¯ãªãããªããªãã°ç©è³ªãæ¶å管å ã«
ååšããæéãé·ãããšã«ããããããŠäžè¬çãª
æ¶åéçšã«ããåžåãä¿é²ãããããã§ãããã
ã¡ãã極ããŠé£æº¶æ§ã®ç©è³ªã¯çµå£æäžããå Žåã«
ãã€ãããšåžåãããã ãã§ãããæäžãããè¬
ç©ã®äžéšã¯ææ³ãããå¯èœæ§ããããåŸã€ãŠå å
ã«æãŸããè¬ç©ã®å¹æãçºæ®ã§ããªããåŸã€ãŠã
ã®ãããªç©è³ªã®æº¶è§£åºŠãæ¹åããããã®æ¹æ³ã¯æ
å¹ãªçµå£çæè¬åœ¢æ ã補é ããããã«é©çšããã
ã°ãªããªããåœæ¥è ã«ãããŠç¥ãããŠãããã®ã
ããªæ¹æ³ã®äžã€ã¯è¬ç©ã®æº¶è§£æ§ã®å¡©ã補é ããã
ãšã§ããã å€ãã®å Žåã«çµå£çãªæäžçµè·¯ã¯äœ¿çšããããš
ãã§ããªãããŸãã¯å¥œãŸãããªããããšãã°äººã«
ããã埮çç©ææãæ²»çããå Žåã«ã¯ãéçµå£ç
ãªæäžçµè·¯ããã°ãã°å¥œãŸããããŸãå®éã«å¿ èŠ
ã§ããã ããšãã°ç¹å®æèå€ã®é«ãè¡äžæ¿åºŠãè¿ éã«åŸ
ãããã«ã¯éèå æäžããã°ãã°äœ¿çšããããé·
æéã«ããã€ãŠç¹å®ãšè¡äžã¬ãã«ãä¿æãããã
ã«ãã€ããããéèå æ³šå ¥ã䜿çšããããšãã§ã
ããå°å ç§ã®è匱ãªãŸãã¯ç¡æèã®æ£è ãæ²»çã
ãããã«ã¯çèå ããã³éèå 泚å°ã䜿çšããã
ãšãã§ããã å®å®ãªéçµå£çæè¬åœ¢æ ã補é ãããããããŸ
ãã¯äœ¿çšçŽåã«éçµå£çãªæè¬åœ¢æ ã«ããããšã
ã§ããå®å®ãªæè¬åœ¢æ ã補é ããããã«å¿ èŠãªæŽ»
æ§æåã®ç¹åŸŽã¯ãåäžã®æŽ»æ§æåãå«æããçµå£
çæè¬åœ¢æ ã«å¯ŸããŠèŠæ±ããããã®ãšã¯ç°ãªã€ãŠ
ããããã®ããã«éçµå£çåŠæ¹ç©ã«å¯ŸããŠã¯æŽ»æ§
æåã¯ããèªäœå°ãªããšã以äžã®ç¹åŸŽãæããŠã
ãªããã°ãªããªããããŸãã¯ãã®ãããªç¹åŸŽãæ
ããèªå°äœïŒããšãã°å¡©ïŒã«å€æããªããã°ãªã
ãªãã (a) è¡æ¶²ããã³çèçµç¹ãšé©åãããããŠçŽ°èæ§
é ãå·ã€ããªããããªPH奜ãŸããã¯çŽPHïŒãïŒ
ã«ãããæ°Žäžã§ã®é«ã溶解床ã (b) 奜ãŸããã¯å®€æž©ã§äžã€ç©ºæ°ã®ååšäžã«ããã
溶液äžã§ã®å®å®æ§ã (c) æ¯èŒçç¡æ¯æ§ã§äžã€è¬å€èª¿ç¯äœçšã«é¢ããŠèš±
容ãããè©Šè¬ïŒããªãã¡é žãŸãã¯å¡©åºïŒãçšã
ãŠèªå°äœåãããã (d) èªå°äœåè©Šè¬ã¯æ¯èŒçå®äŸ¡ã§ããã¹ãã§ã
ãã (e) èªå°äœã¯å®¹æã«çæããããããŠåçµä¹Ÿç¥ã«
ããå®å®ãªåœ¢æ ãçæãã¹ãã§ããã (f) èªå°äœã¯äŸ¿å©ã«æäžããããã®æšæºçãªéçµ
å£ç溶液ãšé©åãããããŠããã«å åã«æº¶è§£ã
ã¹ãã§ããã æè¿ïŒçš®ã®æ°èŠãªæèå€ãå ±åããããããšã
ã°ïŒâãšãã«âïŒâãã«ãªãâïŒïŒïŒâãžããã
âïŒâãªããœâïŒâïŒïŒâããã©ãžãã«ïŒâïŒâã
ããªã³ã«ã«ãã³é žïŒä»¥äžå Žåã«ãããååç©ïŒ¡ã
ãšç§°ããïŒã®æèäœçšã¯ãAntimicrobial Agent
and Chemotherapyã第17巻第103ã108é ïŒ1980
幎ïŒããã³ãAntimicrobial Agents and
Chemotherapyã第19巻第188ã189é ïŒ1981幎ïŒ
ã«å ±åãããŠããããããã¯åç §ãšããŠæ¬æ现æž
äžã«å«ãŸãããïŒâãšãã«âïŒâãã«ãªãâïŒïŒ
ïŒâãžãããâïŒâãªããœâïŒâïŒïŒâããã©ãž
ãã«ïŒâïŒïŒïŒâããããªãžã³âïŒâã«ã«ãã³é ž
ïŒä»¥äžå Žåã«ãããååç©ïŒ¢ããšç§°ããïŒã®æè
äœçšã¯ãCurrent Chemotherapy and
Infectious Diseaseã Proceedings of the
11th International Congress of Chemotherapy
and the 19th Interscience Conference on
Antimicrobial Agents and Chemotherapyã第
ïŒå·»ç¬¬451é ïŒã¢ã¡ãªã«åŸ®çç©åŠäŒ1980幎çºè¡ïŒ
ã«å ±åãããŠããããã®æç®ã¯åç §ãšããŠæ¬æ现
æžäžã«å«ãŸããã ååç©ïŒ¡ã¯ãŸãç±³åœç¹èš±ç¬¬4146719å·æ现æžã«
ãèšèŒãããŠãããããã¯åç §ãšããŠæ¬æ现æžäž
ã«å«ãŸããããã®ååç©ã¯äž¡æ§ã§ããããããŠé«
床ã®æ°Žæº¶æ§ãæããªãããã®ç¹èš±ã«ã¯å¡©é žå¡©ã®è£œ
é ã ããé瀺ãããŠããã以äžã«è«è°ãããçç±
ã§ãã®å¡©ã¯çš®ã ã®é žããã³å¡©åºãã補é ãããä»
ã®å€ãã®ååç©ïŒ¡ã®å¡©ãšåæ§ã«ãååç©ïŒ¡ãå«æ
ããéçµå£çæè¬åœ¢æ ã補é ããã®ã«ã¯äžé©åœã§
ãããåŸã€ãŠæçšãªéçµå£çæè¬åœ¢æ ã補é ã§ã
ãããã«äžèšã®ç¹åŸŽãæããååç©ïŒ¡ã®èªå°äœã
æäŸããããšã¯æçã§ããäžã€æå©ã§ãããã å¡©é žå¡©ãšããŠã®ååç©ïŒ¢ã¯è±åœç¹èš±åºé¡ç¬¬
2034698å·æ现æžã®å®æœäŸïŒã«ãããŠè£œé ãããŠ
ãããæè¬åœ¢æ ã¯èšèŒãããŠããªãã ååç©ïŒ¢ã¯ãŸããšãŒãããç¹èš±åºé¡ç¬¬9425å·æ
现æžã«ãèšèŒãããŠãããããã¯åç §ãšããŠæ¬æ
现æžäžã«å«ãŸãããååç©ïŒ¢ã¯äž¡æ§ã§ãããé«åºŠ
ã®æ°Žæº¶æ§ãæããªãããã®ç¹èš±ã«ã¯ç¹ã«ååç©ïŒ¢
ã®å¡©ã¯ãçš®ã ã®ç¡æ©é žããã³ææ©é žããçæãã
ããšãã§ãããããŠé©åœãªé žã®äŸã¯å¡©é žãé ¢é žã
ä¹³é žããã¯ãé žãã©ã¯ãããªã³é žããã³ã¡ã¿ã³ã¹
ã«ãã³é žã§ãããç¹ã«å¥œãŸããå¡©ã¯å¡©é žå¡©ãŸãã¯
ã¡ã¿ã³ã¹ã«ãã³é žå¡©ã§ããããšããããšãé瀺ã
ããŠããããã®ç¹èš±ã«ã¯ãŸãå¡©ã補é ããããã«
èé žã䜿çšããããšãã§ãããšèšèŒãããŠããã
以äžã«è«è°ãããçç±ãããããã®å¡©ãªãã³ã«
çš®ã ã®é žããã³å¡©åºãã補é ãããä»ã®å€ãã®å¡©
ã¯ãååç©ïŒ¢ãå«æããæçšãªéçµå£çæè¬åœ¢æ
ã補é ããã®ã«äžé©åœã§ããã ååç©ïŒ¢ã®äœ¿çšã«é¢ããŠã¯ãšãŒãããç¹èš±åºé¡
第9425å·æ现æžã«ã¯ãã®çºæã®ååç©ã¯å»è¬åãš
ããŠããšãã°çµå£çãŸãã¯å±æçé©çšã«é©åœãªæ
æ©ãŸãã¯ç¡æ©ã®è¬åŠçã«èš±å®¹ãããåºäœç¶ãŸãã¯
液äœç¶ã®è£å©å€ãšæ··åããŠããããå«æããè¬åŠ
ç補å€ã®åœ¢æ ã§äœ¿çšã§ããæšèšèŒãããŠãããã
ã®ç¹èš±ã«ã¯ç¶ããŠè¬åŠç補å€ã¯ç²æ«ãé¡ç²å€ãé
å€ãè»èãåå€ãã¯ãªãŒã ãã«ãã»ã«å€ãªã©ã§ã
ã€ãŠãããæšãèšèŒãããŠããã ããã«ãã®ç¹èš±ã«å ±åãããŠãããã¹ãŠã®çäœ
å è©Šéšæ¹æ³ããªãã¡å®æœäŸïŒ¢ãã§ã¯çµå£çãæ
äžçµè·¯ã䜿çšãããŠããããããã«æè¬åœ¢æ ã®è£œ
é äŸããªãã¡å®æœäŸïŒšããã³ïŒªãçµå£çæè¬åœ¢æ
ïŒããããã«ãã»ã«å€ããã³é å€ïŒã«å¯ŸããäŸã§
ããã ãããã®çºæè ã¯æçšãªéçµå£çæè¬åœ¢æ ãå
åç©ïŒ¢ãã容æã«è£œé ã§ããªãããšãèªããŠãã
ãšæšæž¬ããããšãã§ããããªããªãã°ãããã®é
èŠãªæè¬åœ¢æ ã®è£œé ããã³äœ¿çšã«é¢ããŠã¯ããã«
æ瀺ãããŠããªããããŸãèæ ®ãããŠãããªãã
ãã§ããã åŸã€ãŠæçšãªéçµå£çæè¬åœ¢æ ã補é ã§ããã
ãã®äžèšã®ç¹åŸŽãæããååç©ïŒ¢ã®èªå°äœãæäŸ
ããããšã¯æçã§äžã€æå©ã§ãããã ååç©ã«é¢ããç·æ¬ç芳ç¹ã«ãããŠæ¬çºæã¯æ§
é åŒïŒ£ ïŒãã ãåŒäžãã¯ïŒ®ãŸãã¯CHã§ããããããŠ
ã¯ã¬ã©ã¯ããŠãã³é žãã¢ã¹ãã©ã®ã³é žãã°ã«ã³
ã³é žãŸãã¯ã°ã«ã¿ãã³é žã§ããïŒãæããååç©
ã«ããã ååç©ã«é¢ãã第ïŒã®äžäœæŠå¿µã«ãããŠæ¬çºæ
ã¯æ§é åŒïŒ€ ïŒãã ãåŒäžãã¯ã¬ã©ã¯ããŠãã³é žãã¢ã¹ãã©
ã®ã³é žãã°ã«ã³ã³é žãŸãã¯ã°ã«ã¿ãã³é žã§ããïŒ
ãæããååç©ã«ãã ååç©ã«é¢ãã第ïŒã®äžäœæŠå¿µã«ãããŠæ¬çºæ
ã¯æ§é åŒïŒ¥ ïŒãã ãã¯ã¬ã©ã¯ããŠãã³é žãã¢ã¹ãã©ã®ã³
é žãã°ã«ã³ã³é žãŸãã¯ã°ã«ã¿ãã³é žã§ããïŒãæ
ããååç©ã«ããã ååç©ã«é¢ãã第ïŒã®å ·äœç芳ç¹ã«ãããŠæ¬çº
æã¯ïŒâãšãã«âïŒâãã«ãªãâïŒïŒïŒâãžãã
ãâïŒâãªããœâïŒâïŒïŒâããã©ãžãã«ïŒâïŒïŒ
ïŒâããããªãžã³âïŒâã«ã«ãã³é žã¬ã©ã¯ããŠã
ã³é žå¡©ã«ããã ååç©ã«é¢ãã第ïŒã®å ·äœç芳ç¹ã«ãããŠæ¬çº
æã¯ïŒâãšãã«âïŒâãã«ãªãâïŒïŒïŒâãžãã
ãâïŒâãªããœâïŒâïŒïŒâããã©ãžãã«ïŒâïŒïŒ
ïŒâããããªãžã³âïŒâã«ã«ãã³é žã¢ã¹ãã©ã®ã³
é žå¡©ã«ããã ååç©ã«é¢ãã第ïŒã®å ·äœç芳ç¹ã«ãããŠæ¬çº
æã¯ïŒâãšãã«âïŒâãã«ãªãâïŒïŒïŒâãžãã
ãâïŒâãªããœâïŒâïŒïŒâããã©ãžãã«ïŒâïŒïŒ
ïŒâããããªãžã³âïŒâã«ã«ãã³é žã°ã«ã³ã³é žå¡©
ã«ããã ååç©ã«é¢ãã第ïŒã®å ·äœç芳ç¹ã«ãããŠæ¬çº
æã¯ïŒâãšãã«âïŒâãã«ãªãâïŒïŒïŒâãžãã
ãâïŒâãªããœâïŒâïŒïŒâããã©ãžãã«ïŒâïŒïŒ
ïŒâããããªãžã³âïŒâã«ã«ãã³é žã°ã«ã¿ãã³é ž
å¡©ã«ããã ååç©ã«é¢ãã第ïŒã®å ·äœç芳ç¹ã«ãããŠæ¬çº
æã¯ïŒâãšãã«âïŒâãã«ãªãâïŒïŒïŒâãžãã
ãâïŒâãªããœâïŒâïŒïŒâããã©ãžãã«ïŒâïŒâ
ãããªã³ã«ã«ãã³é žã¬ã©ã¯ããŠãã³é žå¡©ã«ããã ååç©ã«é¢ãã第ïŒã®å ·äœç芳ç¹ã«ãããŠæ¬çº
æã¯ïŒâãšãã«âïŒâãã«ãªãâïŒïŒïŒâãžãã
ãâïŒâãªããœâïŒâïŒïŒâããã©ãžãã«ïŒâïŒâ
ãããªã³ã«ã«ãã³é žã¢ã¹ãã©ã®ã³é žå¡©ã«ããã ååç©ã«é¢ãã第ïŒã®å ·äœç芳ç¹ã«ãããŠæ¬çº
æã¯ïŒâãšãã«âïŒâãã«ãªãâïŒïŒïŒâãžãã
ãâïŒâãªããœâïŒâïŒïŒâããã©ãžãã«ïŒâïŒâ
ãããªã³ã«ã«ãã³é žã°ã«ã³ã³é žå¡©ã«ããã ååç©ã«é¢ãã第ïŒã®å ·äœç芳ç¹ã«ãããŠæ¬çº
æã¯ïŒâãšãã«âïŒâãã«ãªãâïŒïŒïŒâãžãã
ãâïŒâãªããœâïŒâïŒïŒâããã©ãžãã«ïŒâïŒâ
ãããªã³ã«ã«ãã³é žã°ã«ã¿ãã³é žå¡©ã«ããã è¬åŠççµæç©ã«é¢ããç·æ¬ç芳ç¹ã«ãããŠæ¬çº
æã¯è¬åŠçã«èš±å®¹ãããæ äœãšçµåãããŠæ§é åŒ
 ïŒãã ãåŒäžãã¯ïŒ®ãŸãã¯CHã§ããããããŠ
ã¯ã¬ã©ã¯ããŠãã³é žãã¢ã¹ãã©ã®ã³é žãã°ã«ã³
ã³é žããŸãã¯ã°ã«ã¿ãã³é žã§ããïŒãæããåå
ç©ãå«ãæèæ§ã®è¬åŠççµæç©ã«ããã è¬åŠççµæç©ã«é¢ãã第ïŒã®äžäœæŠå¿µã«ãããŠ
æ¬çºæã¯è¬åŠçã«èš±å®¹ãããæ äœãšçµåãããŠæ§
é åŒïŒ€ ïŒãã ãåŒäžãã¯ã¬ã©ã¯ããŠãã³é žãã¢ã¹ãã©
ã®ã³é žãã°ã«ã³ã³é žãŸãã¯ã°ã«ã¿ãã³é žã§ããïŒ
ãæããååç©ãå«ãæèæ§ã®è¬åŠççµæç©ã«ã
ãã è¬åŠççµæç©ã«é¢ãã第ïŒã®äžäœæŠå¿µã«ãããŠ
æ¬çºæã¯è¬åŠçã«èš±å®¹ãããæ äœãšçµåãããŠæ§
é åŒïŒ¥ ïŒãã ãåŒäžãã¯ã¬ã©ã¯ããŠãã³é žãã¢ã¹ãã©
ã®ã³é žãã°ã«ã³ã³é žãŸãã¯ã°ã«ã¿ãã³é žã§ããïŒ
ãæããååç©ãå«ãæèæ§ã®è¬åŠççµæç©ã«ã
ãã è¬åŠççµæç©ã«é¢ãã第ïŒã®äžäœæŠå¿µã«ãããŠ
æ¬çºæã¯è¬åŠçã«èš±å®¹ãããæ äœãšçµåããã§æ§
é åŒïŒ£ ïŒãã ãåŒäžãã¯ïŒ®ãŸãã¯CHã§ããããããŠ
ã¯ã¬ã©ã¯ããŠãã³é žãã¢ã¹ãã©ã®ã³é žãã°ã«ã³
ã³é žãŸãã¯ã°ã«ã¿ãã³é žã§ããïŒã®ååç©ãå«ã
æèæ§ã®éçµå£çãªè¬åŠççµæç©ã«ããã è¬åŠçæ¹æ³ã«é¢ããç·æ¬ç芳ç¹ã«ãããŠæ¬çºæ
ã¯æ§é åŒïŒ£ ïŒãã ãåŒäžãã¯ïŒ®ãŸãã¯CHã§ããããããŠ
ã¯ã¬ã©ã¯ããŠãã³é žãã¢ã¹ãã©ã®ã³é žãã°ã«ã³
ã³é žãŸãã¯ã°ã«ã¿ãã³é žã§ããïŒãæããååç©
ã®æå¹äœçšéãäžèšã®ãããªåºä¹³åç©ã«æäžãã
ããšãããªãã现èææçã«ããã€ãŠããåºä¹³å
ç©ã®æ²»çæ¹æ³ã«ããã è¬åŠçæ¹æ³ã«é¢ãã第ïŒã®äžäœæŠå¿µã«ãããŠæ¬
çºæã¯è¬åŠçã«èš±å®¹ãããæ äœãšçµã¿åããã§æ§
é åŒïŒ£ ïŒãã ãåŒäžãã¯ïŒ®ãŸãã¯CHã§ããããããŠ
ã¯ã¬ã©ã¯ããŠãã³é žãã¢ã¹ãã©ã®ã³é žãã°ã«ã³
ã³é žãŸãã¯ã°ã«ã¿ãã³é žã§ããïŒãæããååç©
ãå«ãè¬åŠççµæç©ã®æå¹äœçšéãäžèšã®ãããª
åºä¹³åç©ã«æäžããããšãããªãã现èææçã«
ããã€ãŠããåºä¹³åç©ã®æ²»çæ¹æ³ã«ããã è¬åŠçæ¹æ³ã«é¢ãã第ïŒã®äžäœæŠå¿µã«ãããŠæ¬
çºæã¯ãè¬åŠçã«èš±å®¹ãããéçµå£çæ äœãšçµå
ãããŠæ§é åŒïŒ£ ïŒãã ãåŒäžãã¯ïŒ®ãŸãã¯CHã§ããããããŠ
ã¯ã¬ã©ã¯ããŠãã³é žãã¢ã¹ãã©ã®ã³é žãã°ã«ã³
ã³é žãŸãã¯ã°ã«ã¿ãã³é žã§ããïŒãæããååç©
ãå«ãè¬åŠççµæç©ã®æå¹äœçšéãäžèšã®ãããª
åºä¹³åç©ã«éçµå£çã«æäžããããšãããªãã现
èææçã«ããã€ãŠããåºä¹³åç©ãéçµå£çã«æ²»
çããããã®æ¹æ³ã«ããã ååŠçæ¹æ³ã«é¢ãã芳ç¹ã«ãããŠæ¬çºæã¯æ§é
åŒ ïŒãã ãåŒäžãã¯ä»¥äžã«å®çŸ©ãããïŒãæãã
ååç©ã以äžã«å®çŸ©ããããããªåŒïŒºã®é žãšåå¿
ãããããšãããªãæ§é åŒïŒ£ ïŒãã ãåŒäžãã¯ïŒ®ãŸãã¯CHã§ããããããŠ
ã¯ã¬ã©ã¯ããŠãã³é žãã¢ã¹ãã©ã®ã³é žãã°ã«ã³
ã³é žãŸãã¯ã°ã«ã¿ãã³é žã§ããïŒãæããååç©
ã®è£œé æ³ã«ããã ååç©ïŒ¡ããªãã¡ïŒâãšãã«âïŒâãã«ãªãâ
ïŒïŒïŒâãžãããâïŒâãªããœâïŒâïŒïŒâãã
ã©ãžãã«ïŒâïŒâãããªã³ã«ã«ãã³é žã¯ç±³åœç¹èš±
第4146719å·æ现æžã«èšèŒãããããã«ããŠãã
ãŸãã¯ããã«èšèŒãããæ¹æ³ã®æãããªå€æ³ã«ã
ã補é ããããšãã§ããã ååç©ïŒ¢ããªãã¡ïŒâãšãã«âïŒâãã«ãªãâ
ïŒïŒïŒâãžãããâïŒâãªããœâïŒâïŒïŒâãã
ã©ãžãã«ïŒâïŒïŒïŒâããããªãžã³âïŒâã«ã«ã
ã³é žã¯ãšãŒãããç¹èš±åºé¡ç¬¬9425å·æ现æžã«èšèŒ
ãããããã«ããŠããŸãã¯ããã«èšèŒãããæ¹æ³
ã®æãããªå€æ³ã«ãã補é ããããšãã§ããã ååç©ïŒ¡ããã³ïŒ¢ã¯æ¢ç¥ã®æ¹æ³ã§ææ©ããã³ç¡
æ©ã®é žãçšããŠåŠçããããšã«ãããããã®å¯Ÿå¿
ããé žä»å å¡©ã«å€æããããããšãã°ååç©ïŒ¡ã
ãã³ïŒ¢ã¯æº¶æ¶²ãŸãã¯æžæ¿ç©äžã§åäžã®ããŸãã¯ç°
ãªã€ã溶åªäžã«ææã®é žãå«ã溶液ãŸãã¯æžæ¿ç©
ã§åŠçããããšãã§ãããé©åœãªæº¶åªãŸãã¯æº¶åª
æ··åç©ã¯åœæ¥è ãªãã°å®¹æã«éžæã§ããæ¬çºæã®
奜ãŸãã溶åªã¯æ°Žã§ãããæ°Žäžã§å¡©ã補é ããå Ž
åãæ°Žäžã®ååç©ïŒ¡ãŸãã¯ïŒ¢ã®æžæ¿ç©ãæ°Žã«æº¶è§£
ããŠããããŸãã¯æžæ¿ããŠããéžã°ããé žãšãšã
ã«æ¹æããã溶åªåºŠãé«ãããããŠå¡©åœ¢æãå©ã
ãããã«ãã®æ··åç©ãçæéå æž©ããããšãã§ã
ããããšãã°ãã®æžæ¿ç©ãçŽ60âã«å ç±ãããã
ãŠã€ãã«æ¹æããªãã宀枩ã«æ»ãããšãã§ããã
ã°ã«ã³ã³é žå¡©ã補é ããå Žåãã°ã«ã³ã³é žãã«ã¿
ã©ã¯ãã³ããåå¿ã®å Žã§ã°ã«ã³ã³é žã補é ããã®
ãç¹ã«äŸ¿å©ã§ããããšãèŠãåºãããã ããšãã°ã°ã«ã³ã³é žãã«ã¿ã©ã¯ãã³ãååç©ïŒ¡
ãŸãã¯ïŒ¢ã®æ°Žæžæ¿ç©ã«å ãããããŠå®€æž©ã§çŽ20æ
éæ¹æããããã®æ··åç©ãçŽ60âã«çæéå ç±ã
ããšå®å šãªå¡©åœ¢æã«å¿ èŠãªæéãçŽïŒæéã«ççž®
ããã§ãããã塩圢æãæé©åããããã®ãã®æ¹
æ³ã®å€æŽã¯åœæ¥è ã«ã¯å®¹æã«ã§ããã ååç©ïŒ¡ããã³ïŒ¢ãã»ãŒåœã¢ã«éã®å¡©åœ¢æè©Šè¬
ãšæ··åããããšãã§ãããããŸãã¯ææã«ããé
å°ã®å¡©åœ¢æè©Šè¬ã䜿çšããããšãã§ãããå¡©ã¯æš
æºçãªæ¹æ³ããšãã°åçµä¹Ÿç¥ã«ããååããããš
ãã§ãããã€ãã«ææã«ããå¡©ãåçµæ¶ã«ãã粟
補ããããšãã§ããã æ¬æ现æžäžã§äœ¿çšããå Žåãã¬ã©ã¯ããŠãã³
é žãããã¬ã©ã¯ããŠãã³é žå¡©ãããã¢ã¹ãã©ã®ã³é žãã
ãã¢ã¹ãã©ã®ã³é žå¡©ãããã°ã«ã¿ãã³é žãããã°ã«ã¿
ãã³é žå¡©ãããã°ã¯ã³ã³é žãããã°ã«ã³ã³é žå¡©ããã
ã³ãã°ã«ã³ã³é žãã«ã¿ã©ã¯ãã³ããšããçšèªã«ã¯
ãããã®è©Šè¬ã®ããããã®ç°æ§äœãªãã³ã«ããã
ã®ããããã®ç°æ§äœã®æ··åç©ãå«ãŸãããã®ãšã
ããåŸã€ãŠæ¬çºæã«ãããŠã¯ããšãã°äžèšã®å¡©åœ¢
æè©Šè¬ã®ïŒ€ãããã³DLæ··åç©ã®äœ¿çšãèæ ®ã
ããã奜ãŸãã圢æ ã¯å€©ç¶ã«ååšãã圢ïŒã¢ãã
é žã®å Žåã¯ïŒ¬åœ¢ããããŠã°ã«ã³ã³é žãã°ã«ã³ã³é ž
ãã«ã¿ã©ã¯ãã³ããã³ã¬ã©ã¯ããŠãã³é žã®å Žåã¯
圢ïŒã§ããã æ¬çºæã®ååç©ã¯æº¶åªåãããŠããªã圢ãªãã³
ã«æ°Žåããã圢ãå«ããŠæº¶åªåããã圢ãšããŠå
åšããããšãã§ãããäžè¬çã«è¬åŠçã«èš±å®¹ãã
ã溶åªããšãã°æ°Žããšã¿ããŒã«ãªã©ã§æº¶åªåãã
ã圢ã¯ãæ¬çºæã®ç®çã«å¯ŸããŠæº¶åªåãããŠããª
ã圢ãšåçã§ãããæ¬çºæã®ç®çã«å¯ŸããŠã¯åå
ç©ïŒ¡ããã³ïŒ¢ã®å¥œãŸããå¡©ã¯è¬åŠçã«èš±å®¹ããã
å¡©ã§ããããããŠã¬ã©ã¯ããŠãã³é žå¡©ãã¢ã¹ãã©
ã®ã³é žå¡©ãã°ã«ã¿ãã³é žå¡©ããã³ã°ã«ã³ã³é žå¡©ã§
ãããã°ã«ã³ã³é žå¡©ã¯æã奜ãŸããå¡©ã§ãããã
ããŠïŒ€âã°ã«ã³ã³é žãã«ã¿ã©ã¯ãã³ããåå¿ã®å Ž
ã§çæããâã°ã«ã³ã³é žãã補é ãããå Žåã«
ç¹ã«å¥œãŸããã ååç©ïŒ¡ããã³ïŒ¢ãã補é ãããå€æ°ã®è¬åŠç
ã«èš±å®¹ãããé žä»å å¡©ããã³å¡©åºä»å å¡©ã«é¢ãã
ç 究ã«ãããŠãäžèšã®å¥œãŸããå¡©ç¹ã«ã°ã«ã³ã³é ž
å¡©ã¯ååç©ïŒ¡ããã³ïŒ¢ãå«æããæçšãªéçµå£ç
æè¬åœ¢æ ã補é ããã®ã«å¿ èŠãªç¹åŸŽãæããããš
ãèªãããããååç©ïŒ¡ããã³ïŒ¢ããéçµå£çæ
è¬åœ¢æ ã補é ããããã®ãããã®ç¹æ®ãªå¡©ã®æçš
æ§ã¯é©ãã¹ãããšã§ããããããŠå è¡æè¡ããäº
æ³ããããšã¯ã§ããªãã€ããããšãã°åœæ¥è ã¯å
åç©ïŒ¡ããã³ïŒ¢ãå«æããæçšãªéçµå£çæè¬åœ¢
æ ã¯ãå è¡æè¡ã®æç®ã«é瀺ãããŠããé žä»å å¡©
ãã補é ããããšãã§ãããšèããã§ããããé©
ãã¹ãããšã«ã¯äºå®ã¯ããã§ã¯ãªãããããŠç¹ã«
é©ãã¹ãããšã«ã¯æ¬çºæã®å Žåã«ãååç©ïŒ¡ãã
ã³ïŒ¢ã®äž¡æ¹ããéçµå£çæè¬åœ¢æ ã補é ãããã
ã«ã¯äžè¬çãªå¡©é žå¡©ã®äœ¿çšã¯é€å€ãããã 以äžã®è¡šã«ã¯æº¶è§£åºŠããã³PHã®ããŒã¿ãéã
ããã®ã瀺ãããŠãããããã«ããååç©ïŒ¡ãã
ã³ïŒ¢ãã補é ãããè¬åŠçã«èš±å®¹ãããå¡©ã®å€§éš
åã«ãããã®ååç©ãå«æããæçšãªéçµå£çæ
è¬åœ¢æ ã補é ããããã«å©çšã§ããªãããšã瀺ã
ãŠããã
ãè¡šã
ãè¡šã
è¡šã«éèŒãããããŒã¿ã¯ã€ãã®æº¶è§£åºŠã¹ã¯ãª
ãŒãã³ã°è©Šéšæäœã«ããåŸããããã®ã§ããã éžã°ããæ¿åºŠã«å¯ŸããŠèšç®ãããéã®ååç©ïŒ¡
ãŸãã¯ååç©ïŒ¢ã秀éããŠã¡ã¹ãã©ã¹ã³ã«å ¥ã
ããåœã¢ã«éã®çµåãã¹ãé žãã¢ããé žãŸãã¯å¡©
åºã溶液ãšããŠããŸãã¯ä¹Ÿç¥ééã§å ãããè±ã€
ãªã³æ°Žãäžå®å®¹éãŸã§å ããŠåãã€ãŠéžã°ããæ¿
床ãšãªãããã¹ãŠã®ãã©ã¹ã³ã15åéè¶ é³æ³¢åŠç
ãã30åé宀枩ã§æŸçœ®ããã€ãã«ç®ã®çŽ°ããªã°ã©
ã¹ãã€ã«ã¿ãŒã§éããã液ã®PHã枬å®ããã®
ã¡ã0.1Nå¡©é žã§é©åœã«åžéã玫å€ç·åžåã¹ãã¯
ãã«ã枬å®ããã®ã«é©åœãªæ¿åºŠãšãªããæåã®
液ã®10ååžé液ãæšæºçãªI.V.ïŒéèå æäžçšïŒ
溶液ãšããããããã®åžé液ã®å€èŠ³ãæ²æŸ±çæã«
é¢ããŠèŠ³å¯ããïŒåžéå®éšã®çµæã¯ä»¥äžã®è¡šã
ãã³ã«èšèŒãããŠããïŒã 溶解床ã®ã¹ã¯ãªãŒãã³ã°ã«ãããŠæåã®å®éšãª
æçµæ¿åºŠçŽ25mgïŒmlã®ååç©ïŒ¡ãŸãã¯ïŒ¢ãå«æã
ã溶液ã補é ããããã«è¡ãªãããããã®æ¿åºŠã«
ããããã«å åéã®ç©è³ªãå¯æº¶åããªãã€ããã
ãã®é žãŸãã¯å¡©åºã¯æçšã§ãããšã¯èããããª
ããæçšã§ãããšå€æãããé žãŸãã¯å¡©åºã¯ãã€
ãã«ååç©ïŒ¡ãŸãã¯ïŒ¢ãæäœ150mgïŒmlå«æãã
溶液ãçæããããã«äœ¿çšããããããã«å ããŠ
çŽïŒãçŽïŒã®PHãæãããããã®äžå±€æ¿åãªæº¶æ¶²
ã¯ãã®ã¹ã¯ãªãŒãã³ã°è©Šéšã«éŠå°Ÿããåæ Œãããš
èããããã ååç©ïŒ¡ããã³ïŒ¢ãã補é ãããå¡©ã®äºæ³ã§ã
ãªãã€ãç¹åŸŽã¯è¡šã«èšèŒãããçµæãèãããš
æããã§ããããããã®ç¹åŸŽã¯æçšãªéçµå£çæ
è¬åœ¢æ ã補é ããããã«äžèšã«ç¥èšãããå¿ èŠãª
æ¡ä»¶ïŒïœãïœïŒã«é¢ããŠèæ ®ããããããšãã°å
åç©ïŒ¡ã®å¡©é žå¡©ã¯é©åœãªæº¶è§£åºŠãæããã䜿çšäž
å¯èœãªPHãæããŠãããä»æ¹ååç©ïŒ¢ã®å¡©é žå¡©ã¯
äžé©åœãªæº¶è§£åºŠãæããŠããã°ããã§ãªããŸã䜿
çšäžå¯èœãªPHãæããŠãããååç©ïŒ¡ããã³ïŒ¢ã®
ã¡ã¿ã³ã¹ã«ãã³é žå¡©ããã³ã€ã»ããªã³é žå¡©ã¯è¯å¥œ
ãªæº¶è§£åºŠãæããããPHã«é¢ããŠã¯æºè¶³ã§ããª
ãããŸãâã·ã¹ãã€ã³é žãã補é ãããäž¡æ¹ã®
å¡©ãåæ§ã§ãããååç©ïŒ¡ããã³ïŒ¢äž¡è ã®é ¢é žå¡©
ã¯æçšã§ãããšèããããŠãããããããã¯éŠå°Ÿ
ããåçµä¹Ÿç¥ããããšãã§ãããåŸã€ãŠéå®ãã
ãæçšæ§ãæãããè¡šã®ããŒã¿ãããããã®ä¹³
é žå¡©ã¯æçšã§ãããšèãããããããããªããä¹³
é žã¯çŸåšå ¥æå¯èœãªåæ¥ç圢æ ã§ãããæºè¶³ã§ã
ãççŽã§äžè²«ããŠåŸãããšã¯ã§ãããåŸã€ãŠæçš
ã§ã¯ãªãããã®ã³ãªã³å¡©ããã³ãããªãŠã å¡©ã¯ã
ããã®ããããã®æº¶æ¶²ã®PHã«åºã¥ããŠé€å€ãã
ãã åŸã€ãŠæçšãªå¡©ã¯ã¬ã©ã¯ããŠãã³é žå¡©ãã¢ã¹ã
ã©ã®ã³é žå¡©ãã°ã«ã¿ãã³é žå¡©ãããã³ã°ã«ã³ã³é ž
å¡©ã§ããããšãèŠãåºãããã è¡šã¯è¡šã®çµæãããã«ç¢ºèšŒããŠããããéž
ã°ããåçµä¹Ÿç¥ãããå¡©ããã³çµæ¶åãããå¡©ã®
䜿çšã«çŠç¹ãåãããŠç€ºãããã
ãŒãã³ã°è©Šéšæäœã«ããåŸããããã®ã§ããã éžã°ããæ¿åºŠã«å¯ŸããŠèšç®ãããéã®ååç©ïŒ¡
ãŸãã¯ååç©ïŒ¢ã秀éããŠã¡ã¹ãã©ã¹ã³ã«å ¥ã
ããåœã¢ã«éã®çµåãã¹ãé žãã¢ããé žãŸãã¯å¡©
åºã溶液ãšããŠããŸãã¯ä¹Ÿç¥ééã§å ãããè±ã€
ãªã³æ°Žãäžå®å®¹éãŸã§å ããŠåãã€ãŠéžã°ããæ¿
床ãšãªãããã¹ãŠã®ãã©ã¹ã³ã15åéè¶ é³æ³¢åŠç
ãã30åé宀枩ã§æŸçœ®ããã€ãã«ç®ã®çŽ°ããªã°ã©
ã¹ãã€ã«ã¿ãŒã§éããã液ã®PHã枬å®ããã®
ã¡ã0.1Nå¡©é žã§é©åœã«åžéã玫å€ç·åžåã¹ãã¯
ãã«ã枬å®ããã®ã«é©åœãªæ¿åºŠãšãªããæåã®
液ã®10ååžé液ãæšæºçãªI.V.ïŒéèå æäžçšïŒ
溶液ãšããããããã®åžé液ã®å€èŠ³ãæ²æŸ±çæã«
é¢ããŠèŠ³å¯ããïŒåžéå®éšã®çµæã¯ä»¥äžã®è¡šã
ãã³ã«èšèŒãããŠããïŒã 溶解床ã®ã¹ã¯ãªãŒãã³ã°ã«ãããŠæåã®å®éšãª
æçµæ¿åºŠçŽ25mgïŒmlã®ååç©ïŒ¡ãŸãã¯ïŒ¢ãå«æã
ã溶液ã補é ããããã«è¡ãªãããããã®æ¿åºŠã«
ããããã«å åéã®ç©è³ªãå¯æº¶åããªãã€ããã
ãã®é žãŸãã¯å¡©åºã¯æçšã§ãããšã¯èããããª
ããæçšã§ãããšå€æãããé žãŸãã¯å¡©åºã¯ãã€
ãã«ååç©ïŒ¡ãŸãã¯ïŒ¢ãæäœ150mgïŒmlå«æãã
溶液ãçæããããã«äœ¿çšããããããã«å ããŠ
çŽïŒãçŽïŒã®PHãæãããããã®äžå±€æ¿åãªæº¶æ¶²
ã¯ãã®ã¹ã¯ãªãŒãã³ã°è©Šéšã«éŠå°Ÿããåæ Œãããš
èããããã ååç©ïŒ¡ããã³ïŒ¢ãã補é ãããå¡©ã®äºæ³ã§ã
ãªãã€ãç¹åŸŽã¯è¡šã«èšèŒãããçµæãèãããš
æããã§ããããããã®ç¹åŸŽã¯æçšãªéçµå£çæ
è¬åœ¢æ ã補é ããããã«äžèšã«ç¥èšãããå¿ èŠãª
æ¡ä»¶ïŒïœãïœïŒã«é¢ããŠèæ ®ããããããšãã°å
åç©ïŒ¡ã®å¡©é žå¡©ã¯é©åœãªæº¶è§£åºŠãæããã䜿çšäž
å¯èœãªPHãæããŠãããä»æ¹ååç©ïŒ¢ã®å¡©é žå¡©ã¯
äžé©åœãªæº¶è§£åºŠãæããŠããã°ããã§ãªããŸã䜿
çšäžå¯èœãªPHãæããŠãããååç©ïŒ¡ããã³ïŒ¢ã®
ã¡ã¿ã³ã¹ã«ãã³é žå¡©ããã³ã€ã»ããªã³é žå¡©ã¯è¯å¥œ
ãªæº¶è§£åºŠãæããããPHã«é¢ããŠã¯æºè¶³ã§ããª
ãããŸãâã·ã¹ãã€ã³é žãã補é ãããäž¡æ¹ã®
å¡©ãåæ§ã§ãããååç©ïŒ¡ããã³ïŒ¢äž¡è ã®é ¢é žå¡©
ã¯æçšã§ãããšèããããŠãããããããã¯éŠå°Ÿ
ããåçµä¹Ÿç¥ããããšãã§ãããåŸã€ãŠéå®ãã
ãæçšæ§ãæãããè¡šã®ããŒã¿ãããããã®ä¹³
é žå¡©ã¯æçšã§ãããšèãããããããããªããä¹³
é žã¯çŸåšå ¥æå¯èœãªåæ¥ç圢æ ã§ãããæºè¶³ã§ã
ãççŽã§äžè²«ããŠåŸãããšã¯ã§ãããåŸã€ãŠæçš
ã§ã¯ãªãããã®ã³ãªã³å¡©ããã³ãããªãŠã å¡©ã¯ã
ããã®ããããã®æº¶æ¶²ã®PHã«åºã¥ããŠé€å€ãã
ãã åŸã€ãŠæçšãªå¡©ã¯ã¬ã©ã¯ããŠãã³é žå¡©ãã¢ã¹ã
ã©ã®ã³é žå¡©ãã°ã«ã¿ãã³é žå¡©ãããã³ã°ã«ã³ã³é ž
å¡©ã§ããããšãèŠãåºãããã è¡šã¯è¡šã®çµæãããã«ç¢ºèšŒããŠããããéž
ã°ããåçµä¹Ÿç¥ãããå¡©ããã³çµæ¶åãããå¡©ã®
䜿çšã«çŠç¹ãåãããŠç€ºãããã
ãè¡šã
è¡šããã³ã¯æšæºçãªéèå
æäžã®ããã®æº¶
液äžã§ã®å¡©ã«é¢ããã
液äžã§ã®å¡©ã«é¢ããã
ãè¡šã
ãè¡šã
ãè¡šã
ãè¡šã
æ¬çºæã®ååç©ã¯ã¹ã¿ãã€ãã³ãã«ã¹
ïŒStaphylococcusïŒãã¹ãã¬ããã³ãã«ã¹
ïŒStreptococcusïŒããã¢ãã€ã«ã¹
ïŒHaemophilusïŒããã€ã»ãªã¢ïŒNeisseriaïŒãã¯
ãã¹ããªãžãŠã ïŒClostridiumïŒããšã³ãããã¯ã
ã«ïŒEnterobacterïŒããšã·ãšãªãã¢
ïŒEscherichiaïŒãã¯ã¬ãã·ãšã©ïŒKlebsiellaïŒãã
ãããŠã¹ïŒProteusïŒãããããã³ã·ã¢
ïŒProvidenciaïŒãã·ãŠãŒãã¢ãã¹
ïŒPseudomonasïŒããã³ã»ã©ãã¢ïŒSerratiaïŒå±
ã®åŸ®çç©ã«ç±æ¥ããçŸæ£ãæ²»çããã®ã«æçšã§ã
ãã æ¬çºæã®å¡©ã¯çµå£çã«æäžããããšãã§ãã
ãããããã¯éçµå£çã«æäžããã®ã奜ãŸããã
ãã®å Žåã«æäžéã¯åã ã®æ£è ã®å¿ èŠæ§ããã³è
容æ§ã«ãã調ç¯ããããå€çš®ã®éçµå£ççµè·¯ã®ã
ã¡ã§éèå çµè·¯ãæãŸå¥œãŸããã70Kgã®æ£è ã«å¯Ÿ
ããéåžžã®æäžéç¯å²ã¯ïŒæ¥ãããçŽ70mgããçŽ
21ïœãŸã§ïŒïŒæ¥ãããäœéKgãããïŒmgã300mgïŒ
ã§ããã奜ãŸããã¯ïŒæ¥ããã210mgã6.3ïœïŒïŒ
æ¥ãããäœéKgãããïŒmgã90mgïŒã§ãããå Žå
ã«ããåå²æäžéã§æäžãããã æ¬çºæã®ååç©ã¯æšæºçãªæ¹æ³ã§è©Šéšããå Žå
ã«è©Šéšç®¡å ããã³çäœå ã®äž¡æ¹ã«ãããŠæè掻æ§
ãæããããšãã€ãã®è¡šã«ãããŠèšŒæãããã
ïŒStaphylococcusïŒãã¹ãã¬ããã³ãã«ã¹
ïŒStreptococcusïŒããã¢ãã€ã«ã¹
ïŒHaemophilusïŒããã€ã»ãªã¢ïŒNeisseriaïŒãã¯
ãã¹ããªãžãŠã ïŒClostridiumïŒããšã³ãããã¯ã
ã«ïŒEnterobacterïŒããšã·ãšãªãã¢
ïŒEscherichiaïŒãã¯ã¬ãã·ãšã©ïŒKlebsiellaïŒãã
ãããŠã¹ïŒProteusïŒãããããã³ã·ã¢
ïŒProvidenciaïŒãã·ãŠãŒãã¢ãã¹
ïŒPseudomonasïŒããã³ã»ã©ãã¢ïŒSerratiaïŒå±
ã®åŸ®çç©ã«ç±æ¥ããçŸæ£ãæ²»çããã®ã«æçšã§ã
ãã æ¬çºæã®å¡©ã¯çµå£çã«æäžããããšãã§ãã
ãããããã¯éçµå£çã«æäžããã®ã奜ãŸããã
ãã®å Žåã«æäžéã¯åã ã®æ£è ã®å¿ èŠæ§ããã³è
容æ§ã«ãã調ç¯ããããå€çš®ã®éçµå£ççµè·¯ã®ã
ã¡ã§éèå çµè·¯ãæãŸå¥œãŸããã70Kgã®æ£è ã«å¯Ÿ
ããéåžžã®æäžéç¯å²ã¯ïŒæ¥ãããçŽ70mgããçŽ
21ïœãŸã§ïŒïŒæ¥ãããäœéKgãããïŒmgã300mgïŒ
ã§ããã奜ãŸããã¯ïŒæ¥ããã210mgã6.3ïœïŒïŒ
æ¥ãããäœéKgãããïŒmgã90mgïŒã§ãããå Žå
ã«ããåå²æäžéã§æäžãããã æ¬çºæã®ååç©ã¯æšæºçãªæ¹æ³ã§è©Šéšããå Žå
ã«è©Šéšç®¡å ããã³çäœå ã®äž¡æ¹ã«ãããŠæè掻æ§
ãæããããšãã€ãã®è¡šã«ãããŠèšŒæãããã
ãè¡šã
A ã0.1 0.1
0.2 ã0.1
ã¢ã¹ãã© 0.1 ã0.1
0.2 ã0.1
ã®ã³é žå¡©
ã°ã«ã¿ã ã0.1 ã0.1
0.1 0.1
ã³é žå¡©
ã°ã«ã³ã³ 0.2 ã0.1
0.2 ã0.1
é žå¡©
ã¬ã©ã¯ã 0.1 ã0.1
0.1 ã0.1
ãŠãã³é ž
å¡©
0.2 ã0.1
ã¢ã¹ãã© 0.1 ã0.1
0.2 ã0.1
ã®ã³é žå¡©
ã°ã«ã¿ã ã0.1 ã0.1
0.1 0.1
ã³é žå¡©
ã°ã«ã³ã³ 0.2 ã0.1
0.2 ã0.1
é žå¡©
ã¬ã©ã¯ã 0.1 ã0.1
0.1 ã0.1
ãŠãã³é ž
å¡©
ãè¡šã
ã¢ã¹ãã© ã0.1
0.8 ã0.1
ã®ã³é žå¡©
ã°ã«ã¿ã 0.1
1.6 ã0.1
ã³é žå¡©
ã°ã«ã³ã³ 0.2
1.6 0.2
é žå¡©
ã¬ã©ã¯ã 0.1
0.8 ã0.1
ãŠãã³é ž
å¡©
0.8 ã0.1
ã®ã³é žå¡©
ã°ã«ã¿ã 0.1
1.6 ã0.1
ã³é žå¡©
ã°ã«ã³ã³ 0.2
1.6 0.2
é žå¡©
ã¬ã©ã¯ã 0.1
0.8 ã0.1
ãŠãã³é ž
å¡©
ãè¡šã
é
žå¡©
ã¬ã©ã¯ã 1.6
1.6 0.8
ãŠãã³é ž
å¡©
a ååç©Aã®å«éã«åºã¥ããã®ã§ããã
ã¬ã©ã¯ã 1.6
1.6 0.8
ãŠãã³é ž
å¡©
a ååç©Aã®å«éã«åºã¥ããã®ã§ããã
ãè¡šã
ã¢ã¹ãã© 0.2 ã0.1
0.1 ã0.1
ã®ã³é žå¡©
ã°ã«ã¿ã 0.2 ã0.1
0.2 0.1
ã³é žå¡©
ã°ã«ã³ã³ 0.4 0.1
0.2 0.2
é žå¡©
0.1 ã0.1
ã®ã³é žå¡©
ã°ã«ã¿ã 0.2 ã0.1
0.2 0.1
ã³é žå¡©
ã°ã«ã³ã³ 0.4 0.1
0.2 0.2
é žå¡©
ãè¡šã
ã°ã«ã¿ã 0.2
1.6 ã0.1
ã³é žå¡©
ã°ã«ã³ã³ 0.8
1.6 0.4
é žå¡©
1.6 ã0.1
ã³é žå¡©
ã°ã«ã³ã³ 0.8
1.6 0.4
é žå¡©
ãè¡šã
ã³é
žå¡©
ã°ã«ã³ã³ 3.1
3.1 3.1
é žå¡©
a ååç©Bã®å«éã«åºã¥ããã®ã§ããã
ã°ã«ã³ã³ 3.1
3.1 3.1
é žå¡©
a ååç©Bã®å«éã«åºã¥ããã®ã§ããã
ãè¡šã
ãè¡šã
ãè¡šã
ïŒâãšãã«âïŒâãã«ãªãâïŒïŒïŒâãžããã
âïŒâãªããœâïŒâïŒïŒâããã©ãžãã«ïŒâïŒïŒïŒ
âããããªãžã³âïŒâã«ã«ãã³é žã»ã¹ãæ°Žåç©
1.39ïœïŒïŒããªã¢ã«ïŒãâã°ã«ã³ã³é žÎŽâã©ã¯
ãã³712mgïŒïŒããªã¢ã«ïŒããã³æ°Ž30mlã®æžæ¿ç©
ã宀枩ã§ïŒæéæ¹æããããã®æžæ¿ç©ã55ã60â
ã«çæéå æž©ãããããŠå®€æž©ã§ïŒæéæ¹æãç¶è¡
ãããäžæº¶æ§ç©è³ªãå»ãããããŠæ¶²ãåçµä¹Ÿ
ç¥ãããåºäœåãæ°ŽïŒmlããã³ç¡æ°Žãšã¿ããŒã«24
mlã®æº¶æ¶²ããçµæ¶åãããçµæ¶ãéããç¡æ°Žãš
ã¿ããŒã«ããã³ãšãŒãã«ã§æŽæµãããããŠä¹Ÿç¥ã
ããšçæç©1.08ïœãm.p.165ã167âïŒå解ïŒãã
åŸãããããαã23 DïŒ4.8°ïŒc2ãæ°ŽïŒããã®è©Šæã¯å
åç©ïŒã¢ã«ãããæ°Ž0.7ã¢ã«ãå«æããããšãå
æã«ãã瀺ãããã ãæ³ã ïŒâãšãã«âïŒâãã«ãªãâïŒïŒïŒâãžããã
âïŒâãªããœâïŒâïŒïŒâããã©ãžãã«ïŒâïŒïŒïŒ
âããããªãžã³âïŒâã«ã«ãã³é žã»ã¹ãæ°Žåç©
2.78ïœïŒïŒããªã¢ã«ïŒã2.34Nã®åæ¥çâã°ã«ã³
ã³é žæº¶æ¶²1.21mlïŒ2.8ããªã¢ã«ïŒããã³æ°Ž60mlã®
æžæ¿ç©ã宀枩ã§æ¹æããã12æéåŸã«åæ¥çãªæ°Ž
äžã®ïŒ€âã°ã«ã³ã³é žæº¶æ¶²2.7mlïŒ6.3ããªã¢ã«ïŒã
è¿œå ãããšïŒå以å ã«é»è²æº¶æ¶²ãåŸããããé
ã«ããã®æº¶æ¶²ãéæã«ãããããŠæ¶²ãåçµä¹Ÿç¥
ãããåºäœåãæ°ŽçŽ10mlããã³ç¡æ°Žãšã¿ããŒã«40
mlã®æº¶æ¶²ããçµæ¶åããããã®çµæ¶ã宀枩ã§ïŒæ
éæ¹æããéããç¡æ°Žãšã¿ããŒã«ããã³ãšãŒã
ã«ã§æŽæµãããããŠä¹Ÿç¥ãããšçæç©3.97ïœãm.
p.164ã165°ïŒå解ïŒããåŸãããããαã23 DïŒ4.9°
ïŒc2ãæ°ŽïŒããã®è©Šæã¯ååç©ïŒã¢ã«ãããæ°ŽçŽïŒ
ã¢ã«ãå«æããããšãåæã«ãã瀺ãããã å®æœäŸ ïŒ ïŒâãšãã«âïŒâãã«ãªãâïŒïŒïŒâãžããã
âïŒâãªããœâïŒâïŒïŒâããã©ãžãã«ïŒâïŒâ
ãããªã³ã«ã«ãã³é žïŒ€âã°ã«ã³ã³é žå¡© ãæ³ã ïŒâãšãã«âïŒâãã«ãªãâïŒïŒïŒâãžããã
âïŒâãªããœâïŒâïŒïŒâããã©ãžãã«ïŒâïŒâã
ããªã³ã«ã«ãã³é žã¢ãæ°Žåç©2.7ïœïŒïŒããªã¢
ã«ïŒãâã°ã«ã³ã³é žÎŽâã©ã¯ãã³1.43ïœïŒïŒã
ãªã¢ã«ïŒããã³æ°Ž60mlã®æ··æ¿ç©ã宀枩ã§19.5æé
æ¹æããããã®æº¶æ¶²ãéã«ããéæã«ãããã
ãŠæ¶²ãåçµä¹Ÿç¥ããããã®åºäœåãæ°ŽçŽ10mlã
ãã³ç¡æ°Žãšã¿ããŒã«50mlã®æº¶æ¶²ããçµæ¶åããã
ãã®çµæ¶ãéããç¡æ°Žãšã¿ããŒã«ããã³ãšãŒã
ã«ã§æŽæµãããããŠä¹Ÿç¥ãããšçæç©3.56ïœãm.
p.171ã172âïŒå解ïŒããåŸãããããαã23 DïŒ5.1°
ïŒc2ãæ°ŽïŒããã®è©Šæã¯ååç©ïŒã¢ã«ãããæ°Ž0.1
ã¢ã«ãå«æããããšãåæã«ãã瀺ããããããŠ
ãããã«åžæ¹¿æ§ã§ããã ãæ³ã ïŒâãšãã«âïŒâãã«ãªãâïŒïŒïŒâãžããã
âïŒâãªããœâïŒâïŒïŒâããã©ãžãã«ïŒâïŒâã
ããªã³ã«ã«ãã³é žã¢ãæ°Žåç©0.98ïœïŒ2.9ããªã¢
ã«ïŒãæ°Žäž1.17NDâã°ã«ã³ã³é ž2.48mlïŒ2.9ããªã¢
ã«ïŒïŒåæ¥ç溶液ãåžéããããšã«ããåŸãããïŒ
ããã³æ°Ž20mlã®æžæ¿ç©ã宀枩ã§ïŒæéæ¹æããã
ãã®é»è²æº¶æ¶²ãéã«ããéæã«ãããããŠæ¶²
ãåçµä¹Ÿç¥ãããåºäœåãæ°ŽçŽïŒmlããã³ç¡æ°Žãš
ã¿ããŒã«17mlã®æº¶æ¶²ããçµæ¶åãããçµæ¶ãé
ããç¡æ°Žãšã¿ããŒã«ããã³ãšãŒãã«ã§æŽæµããã
ããŠä¹Ÿç¥ãããšçæç©1.35ïœãm.p.165ã168°ïŒå
解ïŒããçµæ¶ãšããŠåŸãããããαã23 DïŒ5.7°ïŒc2ã
æ°ŽïŒããã®è©Šæã¯ååç©ïŒã¢ã«ãããçŽ0.2ã¢ã«ã®
æ°Žãå«æããããšãåæã«ãã瀺ãããã åæ¥çã°ã«ã³ã³é žæº¶æ¶²ïŒå®æœäŸ6Bããã³7Bã
åç §ïŒãã補é ãããâã°ã«ã³ã³é žå¡©ã¯ïŒ€âã°
ã«ã³ã³é žãã«ã¿ã©ã¯ãã³ã䜿çšããŠè£œé ããã察
å¿ããå¡©ãããäœãå解ç¹ãæããããšãèªãã
ãããåæ¥çâã°ã«ã³ã³é žæº¶æ¶²ãã補é ããã
ã°ã«ã³ã³é žå¡©ã¯ãŸãâã°ã«ã³ã³é žãã«ã¿ã©ã¯ã
ã³ã䜿çšããŠè£œé ããã察å¿ããå¡©ãããæ¿ãç
è²ããŠããïŒããæè²ã®æº¶æ¶²ãåŸãããïŒãåŸã€
ãŠïŒ€âã°ã«ã³ã³é žãã«ã¿ã©ã¯ãã³ã䜿çšããã°ã«
ã³ã³é žå¡©ã®çæã¯æ¬çºæã®å¥œãŸããæ¹æ³ã§ããã å®æœäŸ ïŒ åçµä¹Ÿç¥ããã泚å°å¯èœãªåŠæ¹ç© ã»ã¹ãæ°Žåç©ãšããŠã®ååç©B22.6ïœãâã°
ã«ã³ã³é žÎŽâã©ã¯ãã³23.2ïœã泚å°çšæ°Ž250mlã«
å ãã55âã«çæéå ç±ããïŒæéæ¹æãããšå
æã«å®€æž©ãŸã§å·åŽãããåŸããã溶液ã0.2ÎŒã®
éåšã§éãã4.8ã5.2mlã®æº¶æ¶²ãæ» èãããã
ã€ã¢ã«ã«å å¡«ãããããŠåçµä¹Ÿç¥ããããããã
ã°ã«ã³ã³é žå¡©ãšããŠã®ååç©ïŒ€çŽ645mgããã³é
å°ã®ã°ã«ã³ã³é žçŽ245mgãå«æããçŽ50æ¬ã®ãã€
ã¢ã«ãåŸãããã ã»ã¹ãæ°Žåç©ãšããŠã®ååç©B22.6ïœãâã°
ã«ã³ã³é žÎŽã©ã¯ãã³12.2ïœæ³šå°çšæ°Ž250mlã«å ãã
55°ã«çæéå ç±ãããããŠïŒæéæ¹æãããšå
æã«å®€æž©ãŸã§å·åŽãããåŸããã溶液ã0.2ÎŒã®
éåšã§éãã4.8ã5.2mlã®æº¶æ¶²ãæ» èãããã
ã€ã¢ã«ã«å å¡«ãããããŠåçµä¹Ÿç¥ããããããã
ã°ã«ã³ã³é žå¡©ãšããŠã®ååç©ïŒ€çŽ645mgãå«æã
ããã€ã¢ã«çŽ50æ¬ãåŸãããã ã¢ãæ°Žåç©ãšããŠã®ååç©A21.9ïœãâã°ã«
ã³ã³é žÎŽã©ã¯ãã³23.2ïœã泚å°çšæ°Ž250mlã«å ãã
55âã«çæéå ç±ãããããŠïŒæéæ¹æãããšå
æã«å®€æž©ã«æ»ããåŸããã溶液ã0.2ÎŒã®éåšã§
éãã4.8ã5.2mlã®æº¶æ¶²ãæ» èããããã€ã¢ã«
ã«å å¡«ãããããŠåçµä¹Ÿç¥ãããããããã°ã«ã³
ã³é žå¡©ãšããŠã®ååç©ïŒ¥çŽ645mgããã³éå°ã®ã°
ã«ã³ã³é žçŽ245mgãå«æãããã€ã¢ã«çŽ50æ¬ãåŸ
ãããã ã¢ãæ°Žåç©ãšããŠã®ååç©A21.9ïœãâã°ã«
ã³ã³é žÎŽã©ã¯ãã³23.2ïœã泚å°çšæ°Ž250mlã«å ãã
55âã«çæéå ç±ããçŽïŒæéæ¹æãããšãã®æž©
床ã¯å®€æž©ã«æ»ããåŸããã溶液ã0.2ÎŒã®éåšã§
éãã4.8ã5.2mlã®æº¶æ¶²ãæ» èããããã€ã¢ã«
ã«å å¡«ãããããŠåçµä¹Ÿç¥ãããããããã°ã«ã³
ã³é žå¡©ãšããŠã®ååç©ïŒ¥çŽ645mgãå«æãããã€
ã¢ã«çŽ50æ¬ãåŸãããã å®æœäŸ ïŒ æ³šå°æº¶æ¶² 溶液ã¯å®æœäŸïŒã«èšèŒãããããã«ããŠæ³šå°çš
æ°Ž250mläžã®ååç©ïŒ¢ã»ã¹ãæ°Žåç©22.6ïœããã³
âã°ã«ã³ã³é žÎŽã©ã¯ãã³23.2ïœãã補é ãã
ããåŸããã溶液çŽïŒmlãæ» èãããã¢ã³ãã«50
æ¬ã«ããããå å¡«ãããããŠå¯å°ããã 溶液ã¯å®æœäŸïŒã«èšèŒãããããã«ããŠæ³šå°çš
æ°Ž250mläžã®ååç©ïŒ¡ã¢ãæ°Žåç©21.9ïœãâã°
ã«ã³ã³é žÎŽã©ã¯ãã³23.2ïœãã補é ããããåŸã
ãã溶液çŽïŒmlããããã50æ¬ã®æ» èãããã¢ã³
ãã«ã«å å¡«ãããããŠå¯å°ããã å®æœäŸ 10 ã«ãã»ã«å€ ãã°ã«ã³ã³é žå¡©ãšããŠã®ååç©D100mgã250mgã
ãŸãã¯500mgãå«æããã«ãã»ã«å€ã ååç©ïŒ€ïŒã°ã«ã³ã³é žå¡©ãšããŠïŒ 500ïœ ä¹³ç³ïŒç±³åœè¬å±æ¹ãç¡æ°Žç©ïŒ é©éãŸãã¯200ïœ ã¹ããããã¯ã¹æ«HM ïŒïœ ã°ã«ã³ã³é žå¡©ãšããŠã®ååç©ïŒ€ããã³ä¹³ç³ã匷
åæ¹ææ£ãåãããã€ã³ã·ãšã«ãããµãŒäžã§æ··å
ãããïŒåé転åæ··åããã€ãã§åŒ·åæ¹ææ£ã§ïŒ
åéæ··åããã€ãã«ïŒåéå床転åæ··åãããã€
ãã«æ··åç©ã®äžéšãã¹ããããã¹ã¯æ«ãšæ··åãã
ïŒ30ã®ç¯©ã«éãããããŠãã®æ··åç©ã®æ®ãã«å ã
ããã€ãã«ãã®æ··åãããæåãïŒåéæ··åãã
匷åæ¹ææ£ã§30ç§éæ··åãããããŠããã«ïŒåé
転åæ··åãããé©åœãªãµã€ãºã®ã«ãã»ã«ã«æ··åç©
141mgã352.5mgãŸãã¯705mgãå å¡«ãããšããã
ã100mgã250mgããã³500mgãå«æããã«ãã»ã«
ãåŸãããã ãã°ã«ã³ã³é žå¡©ãšããŠã®ååç©E100mgã250mgãŸ
ãã¯500mgãå«æããã«ãã»ã«ã ååç©ïŒ¥ïŒã°ã«ã³ã³é žå¡©ãšããŠïŒ 500ïœ ä¹³ç³ïŒç±³åœè¬å±æ¹ãç¡æ°Žç©ïŒ é©éãŸãã¯200ïœ ã¹ããããã¯ã¹æ«HM ïŒïœ äžèšãšåæ§ã«æ··åãããããŠå å¡«ãããš100mgã
250mgããã³500mgãå«æããã«ãã»ã«ãçæã
ãã å®æœäŸ 11 é å€ ãã°ã«ã³ã³é žå¡©ãšããŠã®ååç©D100mgã250mgãŸ
ãã¯500mgãå«æããé å€ã ååç©ïŒ€ïŒã°ã«ã³ã³é žå¡©ãšããŠïŒ 500ïœ ããŠã¢ãã³ã·æ®¿ç²NF 200.0ïœ åŸ®æ¶æ§ã»ã«ããŒã¹ 46.0ïœ ã¹ããããã¯ã¹æ«HM 4.0ïœ ç²Ÿè£œæ°Ž é©éãŸãã¯300.0ml ããŠã¢ãã³ã·æ®¿ç²ãã»ã«ããŒã¹ããã³ã°ã«ã³ã³
é žå¡©ãšããŠã®ååç©ïŒ€ããã©ãã¿ãªãŒãããµãŒã«
äžç·ã«å ãããããŠïŒåéæ··åããããã®æ··åç©
ã«æ°Žãå ãããããŠïŒåéæ··åãããåŸãããæ··
åç©ããã¬ãŒäžã§åºããæ°Žåã¬ãã«ãïŒãïŒïŒ ã«
ãªããŸã§ç±é¢šãªãŒãã³äž50âã§ä¹Ÿç¥ãããã€ãã«
ãã®ä¹Ÿç¥ããæ··åç©ããã€ãããã«ïŒFitzmillïŒ
ã§ç²ç ããŠäžçšåºŠã®éãã§ïŒRH2Bã®ç¯©ã«éãã
ã¹ããããã¯ã¹æ«ããã®ç²ç æ··åç©ã«å ãããã
ãŠå šäœããã©ã å転ã«ããïŒåéæ··åãããé©åœ
ãªãµã€ãºã®ãã³ããçšããŠããããå šæ··åç©150
mgã375mgããã³750mgãããªãå§çž®é å€ã補é ã
ãããããã®é å€ã¯ãããã100mgã250mgãŸãã¯
500mgã®æŽ»æ§æåãå«æããã åæ§ã®æ¹æ³ã§ã°ã«ã³ã³é žå¡©ãšããŠã®ååç©ïŒ¥ã
ãé å€ã補é ãããã å®æœäŸ 12 å å€ ïŒïœã®åå€ãããã°ã«ã³ã³é žå¡©ãšããŠã®ååç©
D250mgã500mgãŸãã¯1000mgãå«æããåå€ã次
ã®ããã«åŠæ¹ããã ååç©ïŒ€ïŒã°ã«ã³ã³é žå¡©ãšããŠïŒ
250mg 500mg 1000mg ããªãšãã¬ã³ã°ãªã³ãŒã«1540
1925mg 1750mg 1400mg ããªãšãã¬ã³ã°ãªã³ãŒã«8000
825mg 750mg 600mg ããªãšãã¬ã³ã°ãªã³ãŒã«1540ããã³ããªãšãã¬
ã³ã°ãªã³ãŒã«8000ã60âã§äžç·ã«çèãããããŠ
ãã®çèç©ã«ã°ã«ã³ã³é žå¡©ãšããŠã®ååç©ïŒ€ã溶
解ããããã®å šäœã25âã§åã«å ¥ããŠé©åœãªåå€
ã補é ããã
âïŒâãªããœâïŒâïŒïŒâããã©ãžãã«ïŒâïŒïŒïŒ
âããããªãžã³âïŒâã«ã«ãã³é žã»ã¹ãæ°Žåç©
1.39ïœïŒïŒããªã¢ã«ïŒãâã°ã«ã³ã³é žÎŽâã©ã¯
ãã³712mgïŒïŒããªã¢ã«ïŒããã³æ°Ž30mlã®æžæ¿ç©
ã宀枩ã§ïŒæéæ¹æããããã®æžæ¿ç©ã55ã60â
ã«çæéå æž©ãããããŠå®€æž©ã§ïŒæéæ¹æãç¶è¡
ãããäžæº¶æ§ç©è³ªãå»ãããããŠæ¶²ãåçµä¹Ÿ
ç¥ãããåºäœåãæ°ŽïŒmlããã³ç¡æ°Žãšã¿ããŒã«24
mlã®æº¶æ¶²ããçµæ¶åãããçµæ¶ãéããç¡æ°Žãš
ã¿ããŒã«ããã³ãšãŒãã«ã§æŽæµãããããŠä¹Ÿç¥ã
ããšçæç©1.08ïœãm.p.165ã167âïŒå解ïŒãã
åŸãããããαã23 DïŒ4.8°ïŒc2ãæ°ŽïŒããã®è©Šæã¯å
åç©ïŒã¢ã«ãããæ°Ž0.7ã¢ã«ãå«æããããšãå
æã«ãã瀺ãããã ãæ³ã ïŒâãšãã«âïŒâãã«ãªãâïŒïŒïŒâãžããã
âïŒâãªããœâïŒâïŒïŒâããã©ãžãã«ïŒâïŒïŒïŒ
âããããªãžã³âïŒâã«ã«ãã³é žã»ã¹ãæ°Žåç©
2.78ïœïŒïŒããªã¢ã«ïŒã2.34Nã®åæ¥çâã°ã«ã³
ã³é žæº¶æ¶²1.21mlïŒ2.8ããªã¢ã«ïŒããã³æ°Ž60mlã®
æžæ¿ç©ã宀枩ã§æ¹æããã12æéåŸã«åæ¥çãªæ°Ž
äžã®ïŒ€âã°ã«ã³ã³é žæº¶æ¶²2.7mlïŒ6.3ããªã¢ã«ïŒã
è¿œå ãããšïŒå以å ã«é»è²æº¶æ¶²ãåŸããããé
ã«ããã®æº¶æ¶²ãéæã«ãããããŠæ¶²ãåçµä¹Ÿç¥
ãããåºäœåãæ°ŽçŽ10mlããã³ç¡æ°Žãšã¿ããŒã«40
mlã®æº¶æ¶²ããçµæ¶åããããã®çµæ¶ã宀枩ã§ïŒæ
éæ¹æããéããç¡æ°Žãšã¿ããŒã«ããã³ãšãŒã
ã«ã§æŽæµãããããŠä¹Ÿç¥ãããšçæç©3.97ïœãm.
p.164ã165°ïŒå解ïŒããåŸãããããαã23 DïŒ4.9°
ïŒc2ãæ°ŽïŒããã®è©Šæã¯ååç©ïŒã¢ã«ãããæ°ŽçŽïŒ
ã¢ã«ãå«æããããšãåæã«ãã瀺ãããã å®æœäŸ ïŒ ïŒâãšãã«âïŒâãã«ãªãâïŒïŒïŒâãžããã
âïŒâãªããœâïŒâïŒïŒâããã©ãžãã«ïŒâïŒâ
ãããªã³ã«ã«ãã³é žïŒ€âã°ã«ã³ã³é žå¡© ãæ³ã ïŒâãšãã«âïŒâãã«ãªãâïŒïŒïŒâãžããã
âïŒâãªããœâïŒâïŒïŒâããã©ãžãã«ïŒâïŒâã
ããªã³ã«ã«ãã³é žã¢ãæ°Žåç©2.7ïœïŒïŒããªã¢
ã«ïŒãâã°ã«ã³ã³é žÎŽâã©ã¯ãã³1.43ïœïŒïŒã
ãªã¢ã«ïŒããã³æ°Ž60mlã®æ··æ¿ç©ã宀枩ã§19.5æé
æ¹æããããã®æº¶æ¶²ãéã«ããéæã«ãããã
ãŠæ¶²ãåçµä¹Ÿç¥ããããã®åºäœåãæ°ŽçŽ10mlã
ãã³ç¡æ°Žãšã¿ããŒã«50mlã®æº¶æ¶²ããçµæ¶åããã
ãã®çµæ¶ãéããç¡æ°Žãšã¿ããŒã«ããã³ãšãŒã
ã«ã§æŽæµãããããŠä¹Ÿç¥ãããšçæç©3.56ïœãm.
p.171ã172âïŒå解ïŒããåŸãããããαã23 DïŒ5.1°
ïŒc2ãæ°ŽïŒããã®è©Šæã¯ååç©ïŒã¢ã«ãããæ°Ž0.1
ã¢ã«ãå«æããããšãåæã«ãã瀺ããããããŠ
ãããã«åžæ¹¿æ§ã§ããã ãæ³ã ïŒâãšãã«âïŒâãã«ãªãâïŒïŒïŒâãžããã
âïŒâãªããœâïŒâïŒïŒâããã©ãžãã«ïŒâïŒâã
ããªã³ã«ã«ãã³é žã¢ãæ°Žåç©0.98ïœïŒ2.9ããªã¢
ã«ïŒãæ°Žäž1.17NDâã°ã«ã³ã³é ž2.48mlïŒ2.9ããªã¢
ã«ïŒïŒåæ¥ç溶液ãåžéããããšã«ããåŸãããïŒ
ããã³æ°Ž20mlã®æžæ¿ç©ã宀枩ã§ïŒæéæ¹æããã
ãã®é»è²æº¶æ¶²ãéã«ããéæã«ãããããŠæ¶²
ãåçµä¹Ÿç¥ãããåºäœåãæ°ŽçŽïŒmlããã³ç¡æ°Žãš
ã¿ããŒã«17mlã®æº¶æ¶²ããçµæ¶åãããçµæ¶ãé
ããç¡æ°Žãšã¿ããŒã«ããã³ãšãŒãã«ã§æŽæµããã
ããŠä¹Ÿç¥ãããšçæç©1.35ïœãm.p.165ã168°ïŒå
解ïŒããçµæ¶ãšããŠåŸãããããαã23 DïŒ5.7°ïŒc2ã
æ°ŽïŒããã®è©Šæã¯ååç©ïŒã¢ã«ãããçŽ0.2ã¢ã«ã®
æ°Žãå«æããããšãåæã«ãã瀺ãããã åæ¥çã°ã«ã³ã³é žæº¶æ¶²ïŒå®æœäŸ6Bããã³7Bã
åç §ïŒãã補é ãããâã°ã«ã³ã³é žå¡©ã¯ïŒ€âã°
ã«ã³ã³é žãã«ã¿ã©ã¯ãã³ã䜿çšããŠè£œé ããã察
å¿ããå¡©ãããäœãå解ç¹ãæããããšãèªãã
ãããåæ¥çâã°ã«ã³ã³é žæº¶æ¶²ãã補é ããã
ã°ã«ã³ã³é žå¡©ã¯ãŸãâã°ã«ã³ã³é žãã«ã¿ã©ã¯ã
ã³ã䜿çšããŠè£œé ããã察å¿ããå¡©ãããæ¿ãç
è²ããŠããïŒããæè²ã®æº¶æ¶²ãåŸãããïŒãåŸã€
ãŠïŒ€âã°ã«ã³ã³é žãã«ã¿ã©ã¯ãã³ã䜿çšããã°ã«
ã³ã³é žå¡©ã®çæã¯æ¬çºæã®å¥œãŸããæ¹æ³ã§ããã å®æœäŸ ïŒ åçµä¹Ÿç¥ããã泚å°å¯èœãªåŠæ¹ç© ã»ã¹ãæ°Žåç©ãšããŠã®ååç©B22.6ïœãâã°
ã«ã³ã³é žÎŽâã©ã¯ãã³23.2ïœã泚å°çšæ°Ž250mlã«
å ãã55âã«çæéå ç±ããïŒæéæ¹æãããšå
æã«å®€æž©ãŸã§å·åŽãããåŸããã溶液ã0.2ÎŒã®
éåšã§éãã4.8ã5.2mlã®æº¶æ¶²ãæ» èãããã
ã€ã¢ã«ã«å å¡«ãããããŠåçµä¹Ÿç¥ããããããã
ã°ã«ã³ã³é žå¡©ãšããŠã®ååç©ïŒ€çŽ645mgããã³é
å°ã®ã°ã«ã³ã³é žçŽ245mgãå«æããçŽ50æ¬ã®ãã€
ã¢ã«ãåŸãããã ã»ã¹ãæ°Žåç©ãšããŠã®ååç©B22.6ïœãâã°
ã«ã³ã³é žÎŽã©ã¯ãã³12.2ïœæ³šå°çšæ°Ž250mlã«å ãã
55°ã«çæéå ç±ãããããŠïŒæéæ¹æãããšå
æã«å®€æž©ãŸã§å·åŽãããåŸããã溶液ã0.2ÎŒã®
éåšã§éãã4.8ã5.2mlã®æº¶æ¶²ãæ» èãããã
ã€ã¢ã«ã«å å¡«ãããããŠåçµä¹Ÿç¥ããããããã
ã°ã«ã³ã³é žå¡©ãšããŠã®ååç©ïŒ€çŽ645mgãå«æã
ããã€ã¢ã«çŽ50æ¬ãåŸãããã ã¢ãæ°Žåç©ãšããŠã®ååç©A21.9ïœãâã°ã«
ã³ã³é žÎŽã©ã¯ãã³23.2ïœã泚å°çšæ°Ž250mlã«å ãã
55âã«çæéå ç±ãããããŠïŒæéæ¹æãããšå
æã«å®€æž©ã«æ»ããåŸããã溶液ã0.2ÎŒã®éåšã§
éãã4.8ã5.2mlã®æº¶æ¶²ãæ» èããããã€ã¢ã«
ã«å å¡«ãããããŠåçµä¹Ÿç¥ãããããããã°ã«ã³
ã³é žå¡©ãšããŠã®ååç©ïŒ¥çŽ645mgããã³éå°ã®ã°
ã«ã³ã³é žçŽ245mgãå«æãããã€ã¢ã«çŽ50æ¬ãåŸ
ãããã ã¢ãæ°Žåç©ãšããŠã®ååç©A21.9ïœãâã°ã«
ã³ã³é žÎŽã©ã¯ãã³23.2ïœã泚å°çšæ°Ž250mlã«å ãã
55âã«çæéå ç±ããçŽïŒæéæ¹æãããšãã®æž©
床ã¯å®€æž©ã«æ»ããåŸããã溶液ã0.2ÎŒã®éåšã§
éãã4.8ã5.2mlã®æº¶æ¶²ãæ» èããããã€ã¢ã«
ã«å å¡«ãããããŠåçµä¹Ÿç¥ãããããããã°ã«ã³
ã³é žå¡©ãšããŠã®ååç©ïŒ¥çŽ645mgãå«æãããã€
ã¢ã«çŽ50æ¬ãåŸãããã å®æœäŸ ïŒ æ³šå°æº¶æ¶² 溶液ã¯å®æœäŸïŒã«èšèŒãããããã«ããŠæ³šå°çš
æ°Ž250mläžã®ååç©ïŒ¢ã»ã¹ãæ°Žåç©22.6ïœããã³
âã°ã«ã³ã³é žÎŽã©ã¯ãã³23.2ïœãã補é ãã
ããåŸããã溶液çŽïŒmlãæ» èãããã¢ã³ãã«50
æ¬ã«ããããå å¡«ãããããŠå¯å°ããã 溶液ã¯å®æœäŸïŒã«èšèŒãããããã«ããŠæ³šå°çš
æ°Ž250mläžã®ååç©ïŒ¡ã¢ãæ°Žåç©21.9ïœãâã°
ã«ã³ã³é žÎŽã©ã¯ãã³23.2ïœãã補é ããããåŸã
ãã溶液çŽïŒmlããããã50æ¬ã®æ» èãããã¢ã³
ãã«ã«å å¡«ãããããŠå¯å°ããã å®æœäŸ 10 ã«ãã»ã«å€ ãã°ã«ã³ã³é žå¡©ãšããŠã®ååç©D100mgã250mgã
ãŸãã¯500mgãå«æããã«ãã»ã«å€ã ååç©ïŒ€ïŒã°ã«ã³ã³é žå¡©ãšããŠïŒ 500ïœ ä¹³ç³ïŒç±³åœè¬å±æ¹ãç¡æ°Žç©ïŒ é©éãŸãã¯200ïœ ã¹ããããã¯ã¹æ«HM ïŒïœ ã°ã«ã³ã³é žå¡©ãšããŠã®ååç©ïŒ€ããã³ä¹³ç³ã匷
åæ¹ææ£ãåãããã€ã³ã·ãšã«ãããµãŒäžã§æ··å
ãããïŒåé転åæ··åããã€ãã§åŒ·åæ¹ææ£ã§ïŒ
åéæ··åããã€ãã«ïŒåéå床転åæ··åãããã€
ãã«æ··åç©ã®äžéšãã¹ããããã¹ã¯æ«ãšæ··åãã
ïŒ30ã®ç¯©ã«éãããããŠãã®æ··åç©ã®æ®ãã«å ã
ããã€ãã«ãã®æ··åãããæåãïŒåéæ··åãã
匷åæ¹ææ£ã§30ç§éæ··åãããããŠããã«ïŒåé
転åæ··åãããé©åœãªãµã€ãºã®ã«ãã»ã«ã«æ··åç©
141mgã352.5mgãŸãã¯705mgãå å¡«ãããšããã
ã100mgã250mgããã³500mgãå«æããã«ãã»ã«
ãåŸãããã ãã°ã«ã³ã³é žå¡©ãšããŠã®ååç©E100mgã250mgãŸ
ãã¯500mgãå«æããã«ãã»ã«ã ååç©ïŒ¥ïŒã°ã«ã³ã³é žå¡©ãšããŠïŒ 500ïœ ä¹³ç³ïŒç±³åœè¬å±æ¹ãç¡æ°Žç©ïŒ é©éãŸãã¯200ïœ ã¹ããããã¯ã¹æ«HM ïŒïœ äžèšãšåæ§ã«æ··åãããããŠå å¡«ãããš100mgã
250mgããã³500mgãå«æããã«ãã»ã«ãçæã
ãã å®æœäŸ 11 é å€ ãã°ã«ã³ã³é žå¡©ãšããŠã®ååç©D100mgã250mgãŸ
ãã¯500mgãå«æããé å€ã ååç©ïŒ€ïŒã°ã«ã³ã³é žå¡©ãšããŠïŒ 500ïœ ããŠã¢ãã³ã·æ®¿ç²NF 200.0ïœ åŸ®æ¶æ§ã»ã«ããŒã¹ 46.0ïœ ã¹ããããã¯ã¹æ«HM 4.0ïœ ç²Ÿè£œæ°Ž é©éãŸãã¯300.0ml ããŠã¢ãã³ã·æ®¿ç²ãã»ã«ããŒã¹ããã³ã°ã«ã³ã³
é žå¡©ãšããŠã®ååç©ïŒ€ããã©ãã¿ãªãŒãããµãŒã«
äžç·ã«å ãããããŠïŒåéæ··åããããã®æ··åç©
ã«æ°Žãå ãããããŠïŒåéæ··åãããåŸãããæ··
åç©ããã¬ãŒäžã§åºããæ°Žåã¬ãã«ãïŒãïŒïŒ ã«
ãªããŸã§ç±é¢šãªãŒãã³äž50âã§ä¹Ÿç¥ãããã€ãã«
ãã®ä¹Ÿç¥ããæ··åç©ããã€ãããã«ïŒFitzmillïŒ
ã§ç²ç ããŠäžçšåºŠã®éãã§ïŒRH2Bã®ç¯©ã«éãã
ã¹ããããã¯ã¹æ«ããã®ç²ç æ··åç©ã«å ãããã
ãŠå šäœããã©ã å転ã«ããïŒåéæ··åãããé©åœ
ãªãµã€ãºã®ãã³ããçšããŠããããå šæ··åç©150
mgã375mgããã³750mgãããªãå§çž®é å€ã補é ã
ãããããã®é å€ã¯ãããã100mgã250mgãŸãã¯
500mgã®æŽ»æ§æåãå«æããã åæ§ã®æ¹æ³ã§ã°ã«ã³ã³é žå¡©ãšããŠã®ååç©ïŒ¥ã
ãé å€ã補é ãããã å®æœäŸ 12 å å€ ïŒïœã®åå€ãããã°ã«ã³ã³é žå¡©ãšããŠã®ååç©
D250mgã500mgãŸãã¯1000mgãå«æããåå€ã次
ã®ããã«åŠæ¹ããã ååç©ïŒ€ïŒã°ã«ã³ã³é žå¡©ãšããŠïŒ
250mg 500mg 1000mg ããªãšãã¬ã³ã°ãªã³ãŒã«1540
1925mg 1750mg 1400mg ããªãšãã¬ã³ã°ãªã³ãŒã«8000
825mg 750mg 600mg ããªãšãã¬ã³ã°ãªã³ãŒã«1540ããã³ããªãšãã¬
ã³ã°ãªã³ãŒã«8000ã60âã§äžç·ã«çèãããããŠ
ãã®çèç©ã«ã°ã«ã³ã³é žå¡©ãšããŠã®ååç©ïŒ€ã溶
解ããããã®å šäœã25âã§åã«å ¥ããŠé©åœãªåå€
ã補é ããã
Claims (1)
- ãç¹èš±è«æ±ã®ç¯å²ã ïŒ æ§é åŒïŒ£ ïŒãã ãåŒäžãã¯ïŒ®ãŸãã¯CHã§ããããããŠ
ã¯ã¬ã©ã¯ããŠãã³é žãã¢ã¹ãã©ã®ã³é žãã°ã«ã³
ã³é žããŸãã¯ã°ã«ã¿ãã³é žã§ããïŒãæããåå
ç©ã ïŒ æ§é åŒïŒ€ ïŒãã ãåŒäžãã¯ã¬ã©ã¯ããŠãã³é žãã¢ã¹ãã©
ã®ã³é žãã°ã«ã³ã³é žãŸãã¯ã°ã«ã¿ãã³é žã§ããïŒ
ãæããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé èšèŒã®ååç©ã ïŒ æ§é åŒïŒ¥ ïŒãã ãåŒäžãã¯ã¬ã©ã¯ããŠãã³é žãã¢ã¹ãã©
ã®ã³é žãã°ã«ã³ã³é žãŸãã¯ã°ã«ã¿ãã³é žã§ããïŒ
ãæããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé èšèŒã®ååç©ã ïŒ ïŒâãšãã«âïŒâãã«ãªãâïŒïŒïŒâãžãã
ãâïŒâãªããœâïŒâïŒïŒâããã©ãžãã«ïŒâïŒïŒ
ïŒâããããªãžã³âïŒâã«ã«ãã³é žã¬ã©ã¯ããŠã
ã³é žå¡©ã§ããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé èšèŒã®åå
ç©ã ïŒ ïŒâãšãã«âïŒâãã«ãªãâïŒïŒïŒâãžãã
ãâïŒâãªããœâïŒâïŒïŒâããã©ãžãã«ïŒâïŒïŒ
ïŒâããããªãžã³âïŒâã«ã«ãã³é žã¢ã¹ãã©ã®ã³
é žå¡©ã§ããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé èšèŒã®ååç©ã ïŒ ïŒâãšãã«âïŒâãã«ãªãâïŒïŒïŒâãžãã
ãâïŒâãªããœâïŒâïŒïŒâããã©ãžãã«ïŒâïŒïŒ
ïŒâããããªãžã³âïŒâã«ã«ãã³é žã°ã«ã³ã³é žå¡©
ã§ããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé èšèŒã®ååç©ã ïŒ ïŒâãšãã«âïŒâãã«ãªãâïŒïŒïŒâãžãã
ãâïŒâãªããœâïŒâïŒïŒâããã©ãžãã«ïŒâïŒïŒ
ïŒâããããªãžã³âïŒâã«ã«ãã³é žã°ã«ã¿ãã³é ž
å¡©ã§ããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé èšèŒã®ååç©ã ïŒ ïŒâãšãã«âïŒâãã«ãªãâïŒïŒïŒâãžãã
ãâïŒâãªããœâïŒâïŒïŒâããã©ãžãã«ïŒâïŒâ
ãããªã³ã«ã«ãã³é žã¬ã©ã¯ããŠãã³é žå¡©ã§ããç¹
èš±è«æ±ã®ç¯å²ç¬¬ïŒé èšèŒã®ååç©ã ïŒ ïŒâãšãã«âïŒâãã«ãªãâïŒïŒïŒâãžãã
ãâïŒâãªããœâïŒâïŒïŒâããã©ãžãã«ïŒâïŒâ
ãããªã³ã«ã«ãã³é žã¢ã¹ãã©ã®ã³é žå¡©ã§ããç¹èš±
è«æ±ã®ç¯å²ç¬¬ïŒé èšèŒã®ååç©ã ïŒïŒ ïŒâãšãã«âïŒâãã«ãªãâïŒïŒïŒâãžã
ããâïŒâãªããœâïŒâïŒïŒâããã©ãžãã«ïŒâïŒ
âãããªã³ã«ã«ãã³é žã°ã«ã³ã³é žå¡©ã§ããç¹èš±è«
æ±ã®ç¯å²ç¬¬ïŒé èšèŒã®ååç©ã ïŒïŒ ïŒâãšãã«âïŒâãã«ãªãâïŒïŒïŒâãžã
ããâïŒâãªããœâïŒâïŒïŒâããã©ãžãã«ïŒâïŒ
âãããªã³ã«ã«ãã³é žã°ã«ã¿ãã³é žå¡©ã§ããç¹èš±
è«æ±ã®ç¯å²ç¬¬ïŒé èšèŒã®ååç©ã ïŒïŒ æ§é åŒïŒ£ ïŒãã ãåŒäžãã¯ïŒ®ãŸãã¯CHã§ããããããŠ
ã¯ã¬ã©ã¯ããŠãã³é žãã¢ã¹ãã©ã®ã³é žãã°ã«ã³
ã³é žããŸãã¯ã°ã«ã¿ãã³é žã§ããïŒãæããåå
ç©ãå«æããæèæ§ã®è¬åŠççµæç©ã ïŒïŒ è¬åŠçã«èš±å®¹ãããæ äœãçµåãããç¹èš±
è«æ±ã®ç¯å²ç¬¬ïŒïŒé èšèŒã®è¬åŠççµæç©ã ïŒïŒ è¬åŠçã«èš±å®¹ãããæ äœãšçµåãããŠæ§é
åŒïŒ€ ïŒãã ãåŒäžãã¯ã¬ã©ã¯ããŠãã³é žãã¢ã¹ãã©
ã®ã³é žãã°ã«ã³ã³é žãŸãã¯ã°ã«ã¿ãã³é žã§ããïŒ
ãæããååç©ãå«æããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒïŒ
é èšèŒã®æèæ§ã®è¬åŠççµæç©ã ïŒïŒ è¬åŠçã«èš±å®¹ãããæ äœãšçµåãããŠæ§é
åŒïŒ¥ ïŒãã ãåŒäžãã¯ã¬ã©ã¯ããŠãã³é žãã¢ã¹ãã©
ã®ã³é žãã°ã«ã³ã³é žãŸãã¯ã°ã«ã¿ãã³é žã§ããïŒ
ãæããååç©ãå«æããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒïŒ
é èšèŒã®æèæ§ã®è¬åŠççµæç©ã ïŒïŒ éçµå£çã«äœ¿çšããããã®ç¹èš±è«æ±ã®ç¯å²
第ïŒïŒé èšèŒã®è¬åŠççµæç©ã ïŒïŒ ïŒâãšãã«âïŒâãã«ãªãâïŒïŒïŒâãžã
ããâïŒâãªããœâïŒâïŒïŒâããã©ãžãã«ïŒâ
ïŒïŒïŒâããããªãžã³âïŒâã«ã«ãã³é žã°ã«ã³ã³
é žå¡©ãå«æããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒïŒé èšèŒã®è¬
åŠççµæç©ã ïŒïŒ éçµå£çã«äœ¿çšããããã®ç¹èš±è«æ±ã®ç¯å²
第ïŒïŒé èšèŒã®è¬åŠççµæç©ã ïŒïŒ ïŒâãšãã«âïŒâãã«ãªãâïŒïŒïŒâãžã
ããâïŒâãªããœâïŒâïŒïŒâããã©ãžãã«ïŒâïŒ
âãããªã³ã«ã«ãã³é žã°ã«ã³ã³é žå¡©ãå«æããç¹
èš±è«æ±ã®ç¯å²ç¬¬ïŒïŒé èšèŒã®è¬åŠççµæç©ã ïŒïŒ éçµå£çã«äœ¿çšããããã®ç¹èš±è«æ±ã®ç¯å²
第ïŒïŒé èšèŒã®è¬åŠççµæç©ã ïŒïŒ æ§é åŒ ïŒãã ãåŒäžãã¯äžèšã«å®çŸ©ããããšããã§ã
ãïŒãæããååç©ãäžèšã«å®çŸ©ããããããªåŒ
ã®é žãšåå¿ãããããšãããªãæ§é åŒïŒ£ ïŒãã ãåŒäžãã¯ïŒ®ãŸãã¯CHã§ããããããŠ
ã¯ã¬ã©ã¯ããŠãã³é žãã¢ã¹ãã©ã®ã³é žãã°ã«ã³
ã³é žãŸãã¯ã°ã«ã¿ãã³é žã§ããïŒãæããååç©
ã®è£œé æ³ã
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US27260181A | 1981-06-11 | 1981-06-11 | |
| US272601 | 1981-06-11 | ||
| US334182 | 1981-12-24 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS58966A JPS58966A (ja) | 1983-01-06 |
| JPH0315632B2 true JPH0315632B2 (ja) | 1991-03-01 |
Family
ID=23040486
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP57098576A Granted JPS58966A (ja) | 1981-06-11 | 1982-06-10 | æèæ§ããããªãžã³ããã³ãããªã³ååç©ã®å¡© |
Country Status (2)
| Country | Link |
|---|---|
| JP (1) | JPS58966A (ja) |
| ZA (1) | ZA824096B (ja) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6375917B1 (en) | 1984-12-06 | 2002-04-23 | Hyperion Catalysis International, Inc. | Apparatus for the production of carbon fibrils by catalysis and methods thereof |
| AU2008239966C1 (en) * | 2007-04-13 | 2012-03-29 | Dong Wha Pharmaceutical Co., Ltd. | Aspartate of 1-cyclopropyl-6-fluoro-7-(8-methoxyimino-2,6-diaza- spiro[3.4]oct-6-yl)-4-oxo-1,4-dihydro-[1,8]naphthyridine-3-carboxylic acid, method for preparing the same, and antimicrobial pharmaceutical composition comprising the same |
| KR101468659B1 (ko) * | 2009-07-27 | 2014-12-05 | 죌ìíì¬ ì늬ë°ìŽì€ | -7-(3-ìë¯žë žë©íž-4-ë©í¡ììŽë¯žë ž-3-ë©íž-íŒë¡€ëŠ¬ë-1-ìŒ)-1-ìíŽë¡íë¡í-6-í룚ì€ë¡-4-ì¥ì-1,4-ëíëë¡-[1,8]ëíí°ëŠ¬ë-3-칎륎복ì€ì° ïœ-ìì€í륎ížì°ìŒ, ìŽì ì ì¡°ë°©ë² ë° ìŽë¥Œ í¬íšíë íê· ì© ìœíì ì¡°ì±ë¬Œ |
-
1982
- 1982-06-10 ZA ZA824096A patent/ZA824096B/xx unknown
- 1982-06-10 JP JP57098576A patent/JPS58966A/ja active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| ZA824096B (en) | 1983-04-27 |
| JPS58966A (ja) | 1983-01-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0067666B1 (en) | Salts of antimicrobial naphthyridine and quinoline compounds and their production | |
| JPS5923313B2 (ja) | ïŒïŒïŒã«ããã³ã®æ°Žæº¶æ§è€å¡©ããã³ãã®è£œé æ¹æ³ | |
| JPS638354A (ja) | ãžã¢ã»ãã«ã©ã€ã³å¡©åã³é¢ç¯çã®æ²»çã«ããããããã®äœ¿çš | |
| JPH0144185B2 (ja) | ||
| JPH0245634B2 (ja) | ||
| WO2007082471A1 (fr) | Composé antii-nfectieux, son procédé de préparation et son utilisation | |
| JPS5925377A (ja) | ã¡ãããããŸâã«ãšïœïŒïœâãžã¡ãã«ã°ãªã·ã³ãšã®ãšã¹ãã«ããã³ãã®é žä»å 湿 | |
| JPH03503162A (ja) | ååŠçæ³ã«ãããæ¯æ§ç¹æ§ã®æ¹è¯ | |
| US4352813A (en) | [(1-Benzyl-1H-indazol-3-yl)oxy] acetic acid salt with L. lysine | |
| FI71319B (fi) | Foerfarande foer framstaellning av terapeutiskt anvaendbart vicaminsackarinat | |
| JPS6317836B2 (ja) | ||
| JPH0365338B2 (ja) | ||
| US4001231A (en) | Process for making a methenamine salt of an optically active acid | |
| JPS58966A (ja) | æèæ§ããããªãžã³ããã³ãããªã³ååç©ã®å¡© | |
| KR20000069376A (ko) | ë°ì€í늬ì¥ì¬ë¯Œì ì ì ë° ë€í íí, ë° ìŽì ì ì¡° ë°©ë² | |
| JP4130700B2 (ja) | æè «çå€å«æçµæç© | |
| JPH0149693B2 (ja) | ||
| CN105017281A (zh) | äžç±»å®åŠ¥æ²æççåå ¶å¶å€æ¹æ³åçšé | |
| CA1151153A (en) | Penicillin salt | |
| SU869560A3 (ru) | СпПÑПб пПлÑÑеМО заЌеÑеММÑÑ 7-(5-ПкÑП-4-ÑеМОлОЌОЎазПлОЎОМ-1-Ол)-3-Ñ Ð»ÐŸÑ-3-ÑеÑеЌ-4-каÑбПМПвÑÑ ÐºÐžÑÐ»ÐŸÑ | |
| US4322424A (en) | Crystalline glucoconate salt of m-AMSA and compositions containing same | |
| JPWO1997030706A1 (ja) | æè «çå€å«æçµæç© | |
| CN102079717A (zh) | äžç§äºå é ¯é žçç²Ÿæ°šé žçååç©åå ¶å¶å€æ¹æ³åè¯ç©åºçš | |
| US2746972A (en) | Thiophene-2-carboxaldehyde thiosemicarbazone and certain substitution derivatives | |
| AU2010277947A1 (en) | R-7-(3-aminomethyl-4-methoxyimino-3-methyl-pyrrolidin-1-yl)-1-cyclopropyl- 6-fluoro-4-oxo-1,4-dihydro-[1,8]naphthyridine-3-carboxylic acid and L-aspartic acid salt, process for the preparation thereof and pharmaceutical composition comprising the same for antimicrobial |